1
|
Collomb-Clerc A, Gueguen MCM, Minotti L, Kahane P, Navarro V, Bartolomei F, Carron R, Regis J, Chabardès S, Palminteri S, Bastin J. Human thalamic low-frequency oscillations correlate with expected value and outcomes during reinforcement learning. Nat Commun 2023; 14:6534. [PMID: 37848435 PMCID: PMC10582006 DOI: 10.1038/s41467-023-42380-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/06/2022] [Accepted: 10/09/2023] [Indexed: 10/19/2023] Open
Abstract
Reinforcement-based adaptive decision-making is believed to recruit fronto-striatal circuits. A critical node of the fronto-striatal circuit is the thalamus. However, direct evidence of its involvement in human reinforcement learning is lacking. We address this gap by analyzing intra-thalamic electrophysiological recordings from eight participants while they performed a reinforcement learning task. We found that in both the anterior thalamus (ATN) and dorsomedial thalamus (DMTN), low frequency oscillations (LFO, 4-12 Hz) correlated positively with expected value estimated from computational modeling during reward-based learning (after outcome delivery) or punishment-based learning (during the choice process). Furthermore, LFO recorded from ATN/DMTN were also negatively correlated with outcomes so that both components of reward prediction errors were signaled in the human thalamus. The observed differences in the prediction signals between rewarding and punishing conditions shed light on the neural mechanisms underlying action inhibition in punishment avoidance learning. Our results provide insight into the role of thalamus in reinforcement-based decision-making in humans.
Collapse
Affiliation(s)
- Antoine Collomb-Clerc
- Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France
| | - Maëlle C M Gueguen
- Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France
- Department of Psychiatry, Brain Health Institute and University Behavioral Health Care, Rutgers University-New Brunswick, Piscataway, NJ, USA
| | - Lorella Minotti
- Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France
- Neurology Department, University Hospital of Grenoble, Grenoble, France
| | - Philippe Kahane
- Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France
- Neurology Department, University Hospital of Grenoble, Grenoble, France
| | - Vincent Navarro
- Sorbonne Université, Paris Brain Institute - Institut du Cerveau, ICM, INSERM, CNRS, AP-HP, Pitié-Salpêtrière Hospital, Paris, France
| | - Fabrice Bartolomei
- Timone University Hospital, Sleep Unit, Epileptology and Cerebral Rhythmology, University Hospital of Marseille, Marseille, France
- Aix Marseille University, Inserm, Institut de Neurosciences des Systèmes, Marseille, France
| | - Romain Carron
- Aix Marseille University, Inserm, Institut de Neurosciences des Systèmes, Marseille, France
- Timone University Hospital, Department of functional and stereotactic neurosurgery, University Hospital of Marseille, Marseille, France
| | - Jean Regis
- Neurosurgery Department, University Hospital of Marseille, Marseille, France
| | - Stephan Chabardès
- Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France
- Neurosurgery Department, University Hospital of Grenoble, Grenoble, France
| | - Stefano Palminteri
- Laboratoire de Neurosciences Cognitives Computationnelles, Département d'Etudes Cognitives, ENS, PSL, INSERM, Paris, France
| | - Julien Bastin
- Univ. Grenoble Alpes, Inserm, U1216, CHU Grenoble Alpes, Grenoble Institut Neurosciences, 38000, Grenoble, France.
| |
Collapse
|
2
|
Vorspan F, Domenech P, Grabli D, Yelnik J, Delavest M, Dauré C, Bellivier F, Pelissolo A, Belaid H, Baunez C, Karachi C, Mallet L. A single case report of STN-DBS for severe crack-cocaine dependence: double-blind ON vs. SHAM randomized controlled assessment. Front Psychiatry 2023; 14:1146492. [PMID: 37304434 PMCID: PMC10248431 DOI: 10.3389/fpsyt.2023.1146492] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/17/2023] [Accepted: 04/25/2023] [Indexed: 06/13/2023] Open
Abstract
Crack-cocaine dependence is a severe condition with a high mortality rate. This single case study report details the first deep brain stimulation (DBS) trial targeting the sub-thalamic nucleus (STN) for crack-cocaine dependence. The investigation aimed to assess the effects of STN-DBS on cocaine craving and cocaine use, as well as STN-DBS safety and tolerance in this indication. In this pilot study, we performed double blind cross-over trials, with "ON-DBS" vs. "SHAM-DBS" for 1-month periods. STN-DBS failed to reduce cocaine craving and use. An episode of DBS-induced hypomania occurred after several weeks of cocaine intake at stimulation parameters previously well tolerated. Future research on cocaine dependence should be conducted after a prolonged abstinence period and/or explore novel types of stimulation patterns.
Collapse
Affiliation(s)
- Florence Vorspan
- Université de Paris Cité, INSERM UMRS 1144, Paris, Île-de-France, France
- Assistance Publique - Hôpitaux de Paris, GHU NORD, GH Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, Île-de-France, France
| | - Philippe Domenech
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor - Albert Chenevier, DMU IMPACT, Département Médical-Universitaire de Psychiatrie et d'Addictologie, Créteil, France
| | - David Grabli
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France
- Assistance Publique - Hôpitaux de Paris, GHU Sorbonne Université, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, Île-de-France, France
| | - Jérôme Yelnik
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France
| | - Marine Delavest
- Assistance Publique - Hôpitaux de Paris, GHU NORD, GH Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, Île-de-France, France
| | - Charles Dauré
- Université de Paris Cité, INSERM UMRS 1144, Paris, Île-de-France, France
| | - Frank Bellivier
- Université de Paris Cité, INSERM UMRS 1144, Paris, Île-de-France, France
- Assistance Publique - Hôpitaux de Paris, GHU NORD, GH Lariboisière-Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, Paris, Île-de-France, France
| | - Antoine Pelissolo
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor - Albert Chenevier, DMU IMPACT, Département Médical-Universitaire de Psychiatrie et d'Addictologie, Créteil, France
- Université Paris-Est Créteil, Créteil, Ile-de-France, France
| | - Hayat Belaid
- Assistance Publique - Hôpitaux de Paris, GHU Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Neurochirurgie, Paris, Île-de-France, France
| | - Christelle Baunez
- UMR7289 CNRS & Aix-Marseille Université, Marseille, Provence-Alpes-Côôte-d'Azur, France
| | - Carine Karachi
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France
- Assistance Publique - Hôpitaux de Paris, GHU Sorbonne Université, Hôpital Pitié-Salpêtrière, Service de Neurochirurgie, Paris, Île-de-France, France
| | - Luc Mallet
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM U1127, CNRS UMR 7225, Paris, Île-de-France, France
- Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor - Albert Chenevier, DMU IMPACT, Département Médical-Universitaire de Psychiatrie et d'Addictologie, Créteil, France
- Department of Mental Health and Psychiatry, Global Health Institute, University of Geneva, Geneva, Switzerland
| |
Collapse
|
3
|
Temiz G, Atkinson-Clement C, Lau B, Czernecki V, Bardinet E, Francois C, Worbe Y, Karachi C. Structural hyperconnectivity of the subthalamic area with limbic cortices underpins anxiety and impulsivity in Tourette syndrome. Cereb Cortex 2022; 33:5181-5191. [PMID: 36310093 DOI: 10.1093/cercor/bhac408] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2022] [Revised: 09/15/2022] [Accepted: 09/16/2022] [Indexed: 11/12/2022] Open
Abstract
Abstract
Tourette syndrome (TS) is a neurodevelopmental disorder characterized by motor and vocal tics, which is often associated with psychiatric comorbidities. Dysfunction of basal ganglia pathways might account for the wide spectrum of symptoms in TS patients. Although psychiatric symptoms may be related to limbic networks, the specific contribution of different limbic structures remains unclear. We used tractography to investigate cortical connectivity with the striatal area (caudate, putamen, core and shell of the nucleus accumbens), the subthalamic nucleus (STN), and the adjacent medial subthalamic region (MSR) in 58 TS patients and 35 healthy volunteers. 82% of TS patients showed psychiatric comorbidities, with significantly higher levels of anxiety and impulsivity compared to controls. Tractography analysis revealed significantly increased limbic cortical connectivity of the left MSR with the entorhinal (BA34), insular (BA48), and temporal (BA38) cortices in TS patients compared to controls. Furthermore, we found that left insular-STN connectivity was positively correlated with impulsivity scores for all subjects and with anxiety scores for all subjects, particularly for TS. Our study highlights a heterogenous modification of limbic structure connectivity in TS, with specific abnormalities found for the subthalamic area. Abnormal connectivity with the insular cortex might underpin the higher level of impulsivity and anxiety observed in TS.
Collapse
Affiliation(s)
- Gizem Temiz
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
| | - Cyril Atkinson-Clement
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
| | - Brian Lau
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
| | - Virginie Czernecki
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
- Department of Neurology, Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris , 75013 Paris, France
| | - Eric Bardinet
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
| | - Chantal Francois
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
| | - Yulia Worbe
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
- Department of Neurophysiology, Saint Antoine Hospital, Assistance Publique-Hôpitaux de Paris , 75012 Paris, France
| | - Carine Karachi
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute- ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière , 75013 Paris, France
- Department of Neurosurgery, Pitié Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris , 75013 Paris, France
| |
Collapse
|
4
|
Pujol S, Cabeen RP, Yelnik J, François C, Fernandez Vidal S, Karachi C, Bardinet E, Cosgrove GR, Kikinis R. Somatotopic Organization of Hyperdirect Pathway Projections From the Primary Motor Cortex in the Human Brain. Front Neurol 2022; 13:791092. [PMID: 35547388 PMCID: PMC9081715 DOI: 10.3389/fneur.2022.791092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2021] [Accepted: 03/04/2022] [Indexed: 11/25/2022] Open
Abstract
Background The subthalamic nucleus (STN) is an effective neurosurgical target to improve motor symptoms in Parkinson's Disease (PD) patients. MR-guided Focused Ultrasound (MRgFUS) subthalamotomy is being explored as a therapeutic alternative to Deep Brain Stimulation (DBS) of the STN. The hyperdirect pathway provides a direct connection between the cortex and the STN and is likely to play a key role in the therapeutic effects of MRgFUS intervention in PD patients. Objective This study aims to investigate the topography and somatotopy of hyperdirect pathway projections from the primary motor cortex (M1). Methods We used advanced multi-fiber tractography and high-resolution diffusion MRI data acquired on five subjects of the Human Connectome Project (HCP) to reconstruct hyperdirect pathway projections from M1. Two neuroanatomy experts reviewed the anatomical accuracy of the tracts. We extracted the fascicles arising from the trunk, arm, hand, face and tongue area from the reconstructed pathways. We assessed the variability among subjects based on the fractional anisotropy (FA) and mean diffusivity (MD) of the fibers. We evaluated the spatial arrangement of the different fascicles using the Dice Similarity Coefficient (DSC) of spatial overlap and the centroids of the bundles. Results We successfully reconstructed hyperdirect pathway projections from M1 in all five subjects. The tracts were in agreement with the expected anatomy. We identified hyperdirect pathway fascicles projecting from the trunk, arm, hand, face and tongue area in all subjects. Tract-derived measurements showed low variability among subjects, and similar distributions of FA and MD values among the fascicles projecting from different M1 areas. We found an anterolateral somatotopic arrangement of the fascicles in the corona radiata, and an average overlap of 0.63 in the internal capsule and 0.65 in the zona incerta. Conclusion Multi-fiber tractography combined with high-resolution diffusion MRI data enables the identification of the somatotopic organization of the hyperdirect pathway. Our preliminary results suggest that the subdivisions of the hyperdirect pathway projecting from the trunk, arm, hand, face, and tongue motor area are intermixed at the level of the zona incerta and posterior limb of the internal capsule, with a predominantly overlapping topographical organization in both regions. Subject-specific knowledge of the hyperdirect pathway somatotopy could help optimize target definition in MRgFUS intervention.
Collapse
Affiliation(s)
- Sonia Pujol
- Surgical Planning Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
| | - Ryan P Cabeen
- Laboratory of Neuro Imaging, Stevens Institute for Neuroimaging and Informatics, Keck School of Medicine of the USC, University of Southern California, Los Angeles, CA, United States
| | - Jérôme Yelnik
- Sorbonne Université, CNRS, INSERM, APHP GH Pitié-Salpêtriére, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.,CENIR Platform, Institut du Cerveau (ICM), Paris, France
| | - Chantal François
- Sorbonne Université, CNRS, INSERM, APHP GH Pitié-Salpêtriére, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.,CENIR Platform, Institut du Cerveau (ICM), Paris, France
| | - Sara Fernandez Vidal
- Sorbonne Université, CNRS, INSERM, APHP GH Pitié-Salpêtriére, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.,CENIR Platform, Institut du Cerveau (ICM), Paris, France
| | - Carine Karachi
- Sorbonne Université, CNRS, INSERM, APHP GH Pitié-Salpêtriére, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.,CENIR Platform, Institut du Cerveau (ICM), Paris, France.,Department of Neurosurgery, APHP, Hôpitaux Universitaires Pitié-Salpêtriére/Charles Foix, Paris, France
| | - Eric Bardinet
- Sorbonne Université, CNRS, INSERM, APHP GH Pitié-Salpêtriére, Paris Brain Institute - Institut du Cerveau (ICM), Paris, France.,CENIR Platform, Institut du Cerveau (ICM), Paris, France
| | - G Rees Cosgrove
- Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
| | - Ron Kikinis
- Surgical Planning Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States
| |
Collapse
|
5
|
Yu B, Li L, Guan X, Xu X, Liu X, Yang Q, Wei H, Zuo C, Zhang Y. HybraPD atlas: Towards precise subcortical nuclei segmentation using multimodality medical images in patients with Parkinson disease. Hum Brain Mapp 2021; 42:4399-4421. [PMID: 34101297 PMCID: PMC8357000 DOI: 10.1002/hbm.25556] [Citation(s) in RCA: 13] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Revised: 05/27/2021] [Accepted: 05/30/2021] [Indexed: 12/29/2022] Open
Abstract
Human brain atlases are essential for research and surgical treatment of Parkinson's disease (PD). For example, deep brain stimulation for PD often requires human brain atlases for brain structure identification. However, few atlases can provide disease-specific subcortical structures for PD, and most of them are based on T1w and T2w images. In this work, we construct a HybraPD atlas using fused quantitative susceptibility mapping (QSM) and T1w images from 87 patients with PD. The constructed HybraPD atlas provides a series of templates, that is, T1w, GRE magnitude, QSM, R2*, and brain tissue probabilistic maps. Then, we manually delineate a parcellation map with 12 bilateral subcortical nuclei, which are highly related to PD pathology, such as sub-regions in globus pallidus and substantia nigra. Furthermore, we build a whole-brain parcellation map by combining existing cortical parcellation and white-matter segmentation with the proposed subcortical nuclei map. Considering the multimodality of the HybraPD atlas, the segmentation accuracy of each nucleus is evaluated using T1w and QSM templates, respectively. The results show that the HybraPD atlas provides more accurate segmentation than existing atlases. Moreover, we analyze the metabolic difference in subcortical nuclei between PD patients and healthy control subjects by applying the HybraPD atlas to calculate uptake values of contrast agents on positron emission tomography (PET) images. The atlas-based analysis generates accurate disease-related brain nuclei segmentation on PET images. The newly developed HybraPD atlas could serve as an efficient template to study brain pathological alterations in subcortical regions for PD research.
Collapse
Affiliation(s)
- Boliang Yu
- School of Information Science and TechnologyShanghaiTech UniversityShanghaiChina
| | - Ling Li
- PET Center, Huashan HospitalFudan UniversityShanghaiChina
| | - Xiaojun Guan
- Department of Radiology, The Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Xiaojun Xu
- Department of Radiology, The Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
| | - Xueling Liu
- Department of Radiology, Huashan HospitalFudan UniversityShanghaiChina
| | - Qing Yang
- Institute of Brain‐Intelligence Technology, Zhangjiang LaboratoryShanghaiChina
| | - Hongjiang Wei
- Institute for Medicine Imaging Technology, School of Biomedical EngineeringShanghai Jiao Tong UniversityShanghaiChina
| | - Chuantao Zuo
- PET Center, Huashan HospitalFudan UniversityShanghaiChina
| | - Yuyao Zhang
- School of Information Science and TechnologyShanghaiTech UniversityShanghaiChina
- Shanghai Engineering Research Center of Intelligent Vision and ImagingShanghaiTech UniversityShanghaiChina
| |
Collapse
|
6
|
Biondetti E, Santin MD, Valabrègue R, Mangone G, Gaurav R, Pyatigorskaya N, Hutchison M, Yahia-Cherif L, Villain N, Habert MO, Arnulf I, Leu-Semenescu S, Dodet P, Vila M, Corvol JC, Vidailhet M, Lehéricy S. The spatiotemporal changes in dopamine, neuromelanin and iron characterizing Parkinson's disease. Brain 2021; 144:3114-3125. [PMID: 33978742 PMCID: PMC8634084 DOI: 10.1093/brain/awab191] [Citation(s) in RCA: 67] [Impact Index Per Article: 22.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2021] [Revised: 04/19/2021] [Accepted: 05/06/2021] [Indexed: 11/13/2022] Open
Abstract
In Parkinson's disease, there is a progressive reduction in striatal dopaminergic function, and loss of neuromelanin-containing dopaminergic neurons and increased iron deposition in the substantia nigra. We tested the hypothesis of a relationship between impairment of the dopaminergic system and changes in the iron metabolism. Based on imaging data of patients with prodromal and early clinical Parkinson's disease, we assessed the spatiotemporal ordering of such changes and relationships in the sensorimotor, associative and limbic territories of the nigrostriatal system. Patients with Parkinson's disease (disease duration < 4 years) or idiopathic REM sleep behaviour disorder (a prodromal form of Parkinson's disease) and healthy controls underwent longitudinal examination (baseline and 2-year follow-up). Neuromelanin and iron sensitive MRI and dopamine transporter single-photon emission tomography were performed to assess nigrostriatal levels of neuromelanin, iron, and dopamine. For all three functional territories of the nigrostriatal system, in the clinically most and least affected hemispheres separately, the following was performed: cross-sectional and longitudinal inter-group difference analysis of striatal dopamine and iron, and nigral neuromelanin and iron; in Parkinson's disease patients, exponential fitting analysis to assess the duration of the prodromal phase and the temporal ordering of changes in dopamine, neuromelanin or iron relative to controls; voxel-wise correlation analysis to investigate concomitant spatial changes in dopamine-iron, dopamine-neuromelanin and neuromelanin-iron in the substantia nigra pars compacta. The temporal ordering of dopaminergic changes followed the known spatial pattern of progression involving first the sensorimotor, then the associative and limbic striatal and nigral regions. Striatal dopaminergic denervation occurred first followed by abnormal iron metabolism and finally neuromelanin changes in the substantia nigra pars compacta, which followed the same spatial and temporal gradient observed in the striatum but shifted in time. In conclusion, dopaminergic striatal dysfunction and cell loss in the substantia nigra pars compacta are interrelated with increased nigral iron content.
Collapse
Affiliation(s)
- Emma Biondetti
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Centre de NeuroImagerie de Recherche - CENIR, 75013 Paris, France.,ICM, Team "Movement Investigations and Therapeutics" (MOV'IT), 75013 Paris, France
| | - Mathieu D Santin
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Centre de NeuroImagerie de Recherche - CENIR, 75013 Paris, France
| | - Romain Valabrègue
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Centre de NeuroImagerie de Recherche - CENIR, 75013 Paris, France
| | - Graziella Mangone
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neurology, Centre d'Investigation Clinique Neurosciences, 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neurology, 75013 Paris, France
| | - Rahul Gaurav
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Centre de NeuroImagerie de Recherche - CENIR, 75013 Paris, France.,ICM, Team "Movement Investigations and Therapeutics" (MOV'IT), 75013 Paris, France
| | - Nadya Pyatigorskaya
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Team "Movement Investigations and Therapeutics" (MOV'IT), 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neuroradiology, 75013 Paris, France
| | | | - Lydia Yahia-Cherif
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Centre de NeuroImagerie de Recherche - CENIR, 75013 Paris, France
| | - Nicolas Villain
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neurology, 75013 Paris, France
| | - Marie-Odile Habert
- Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Nuclear Medicine, 75013 Paris, France.,Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale - LIB, 75006 Paris, France
| | - Isabelle Arnulf
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Team "Movement Investigations and Therapeutics" (MOV'IT), 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Sleep Disorder Unit, 75013 Paris, France
| | - Smaranda Leu-Semenescu
- Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Sleep Disorder Unit, 75013 Paris, France
| | - Pauline Dodet
- Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Sleep Disorder Unit, 75013 Paris, France
| | - Miquel Vila
- Neurodegenerative Diseases Research Group, Vall d'Hebron Research Institute (VHIR)-Center for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED)-Department of Biochemistry and Molecular Biology, Autonomous University of Barcelona (UAB)-Catalan Institution for Research and Advanced Studies (ICREA), 08010 Barcelona, Spain
| | - Jean-Christophe Corvol
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neurology, Centre d'Investigation Clinique Neurosciences, 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neurology, 75013 Paris, France
| | - Marie Vidailhet
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Team "Movement Investigations and Therapeutics" (MOV'IT), 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neurology, 75013 Paris, France
| | - Stéphane Lehéricy
- Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, INSERM, CNRS, 75013 Paris, France.,ICM, Centre de NeuroImagerie de Recherche - CENIR, 75013 Paris, France.,ICM, Team "Movement Investigations and Therapeutics" (MOV'IT), 75013 Paris, France.,Assistance Publique Hôpitaux de Paris, Hôpital Pitié-Salpêtrière, Department of Neuroradiology, 75013 Paris, France
| |
Collapse
|
7
|
Skvortsova V, Palminteri S, Buot A, Karachi C, Welter ML, Grabli D, Pessiglione M. A Causal Role for the Pedunculopontine Nucleus in Human Instrumental Learning. Curr Biol 2021; 31:943-954.e5. [PMID: 33352119 DOI: 10.1016/j.cub.2020.11.042] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/02/2020] [Revised: 09/23/2020] [Accepted: 11/17/2020] [Indexed: 01/06/2023]
Abstract
A critical mechanism for maximizing reward is instrumental learning. In standard instrumental learning models, action values are updated on the basis of reward prediction errors (RPEs), defined as the discrepancy between expectations and outcomes. A wealth of evidence across species and experimental techniques has established that RPEs are signaled by midbrain dopamine neurons. However, the way dopamine neurons receive information about reward outcomes remains poorly understood. Recent animal studies suggest that the pedunculopontine nucleus (PPN), a small brainstem structure considered as a locomotor center, is sensitive to reward and sends excitatory projection to dopaminergic nuclei. Here, we examined the hypothesis that the PPN could contribute to reward learning in humans. To this aim, we leveraged a clinical protocol that assessed the therapeutic impact of PPN deep-brain stimulation (DBS) in three patients with Parkinson disease. PPN local field potentials (LFPs), recorded while patients performed an instrumental learning task, showed a specific response to reward outcomes in a low-frequency (alpha-beta) band. Moreover, PPN DBS selectively improved learning from rewards but not from punishments, a pattern that is typically observed following dopaminergic treatment. Computational analyses indicated that the effect of PPN DBS on instrumental learning was best captured by an increase in subjective reward sensitivity. Taken together, these results support a causal role for PPN-mediated reward signals in human instrumental learning.
Collapse
Affiliation(s)
- Vasilisa Skvortsova
- Motivation, Brain and Behavior (MBB) laboratory, Paris Brain Institute (ICM), Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France; INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France; Laboratoire de Neurosciences Cognitives et Computationnelles, Département d'Etudes Cognitives, Ecole Normale Supérieure, Paris 75005, France; INSERM Unit 960, Université de Paris Sciences et Lettres (UP), 75005 Paris, France; Max Planck UCL Center for Computational Psychiatry and Aging, London WC1B 5EH, UK.
| | - Stefano Palminteri
- Motivation, Brain and Behavior (MBB) laboratory, Paris Brain Institute (ICM), Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France; INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France; Laboratoire de Neurosciences Cognitives et Computationnelles, Département d'Etudes Cognitives, Ecole Normale Supérieure, Paris 75005, France; INSERM Unit 960, Université de Paris Sciences et Lettres (UP), 75005 Paris, France
| | - Anne Buot
- INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France; Laboratoire de Neurosciences Cognitives et Computationnelles, Département d'Etudes Cognitives, Ecole Normale Supérieure, Paris 75005, France; INSERM Unit 960, Université de Paris Sciences et Lettres (UP), 75005 Paris, France
| | - Carine Karachi
- INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France; Neurology and Neurosurgery department, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75013 Paris, France
| | - Marie-Laure Welter
- INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France; Neurophysiology Department, Hôpital Universitaire de Rouen, 76000 Rouen, France
| | - David Grabli
- INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France; Neurology and Neurosurgery department, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, 75013 Paris, France
| | - Mathias Pessiglione
- Motivation, Brain and Behavior (MBB) laboratory, Paris Brain Institute (ICM), Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France; INSERM Unit 1127, CNRS Unit 7225, Sorbonne Universités (SU), Paris 75005, France.
| |
Collapse
|
8
|
Engelhardt J, Caire F, Damon-Perrière N, Guehl D, Branchard O, Auzou N, Tison F, Meissner WG, Krim E, Bannier S, Bénard A, Sitta R, Fontaine D, Hoarau X, Burbaud P, Cuny E. A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease. Stereotact Funct Neurosurg 2020; 99:230-240. [PMID: 33254172 DOI: 10.1159/000511424] [Citation(s) in RCA: 17] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Accepted: 09/07/2020] [Indexed: 11/19/2022]
Abstract
OBJECTIVE Asleep deep brain stimulation (DBS) for Parkinson's disease (PD) is being performed more frequently; however, motor outcomes and safety of asleep DBS have never been assessed in a prospective randomized trial. METHODS We conducted a prospective, randomized, noncomparative trial to assess the motor outcomes of asleep DBS. Leads were implanted in the subthalamic nucleus (STN) according to probabilistic stereotactic coordinates with a surgical robot under O-arm© imaging guidance under either general anesthesia without microelectrode recordings (MER) (20 patients, asleep group) or local anesthesia with MER and clinical testing (9 patients, awake group). RESULTS The mean motor improvement rates on the Unified Parkinson's Disease Rating Scale Part III (UPDRS-3) between OFF and ON stimulation without medication were 52.3% (95% CI: 45.4-59.2%) in the asleep group and 47.0% (95% CI: 23.8-70.2%) in the awake group, 6 months after surgery. Except for a subcutaneous hematoma, we did not observe any complications related to the surgery. Three patients (33%) in the awake group and 8 in the asleep group (40%) had at least one side effect potentially linked with neurostimulation. CONCLUSIONS Owing to its randomized design, our study supports the hypothesis that motor outcomes after asleep STN-DBS in PD may be noninferior to the standard awake procedure.
Collapse
Affiliation(s)
- Julien Engelhardt
- CHU de Bordeaux, Service de Neurochirurgie B, Bordeaux, France, .,Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France, .,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France,
| | - François Caire
- Université de Limoges, CNRS, XLIM, UMR7252, Limoges, France.,CHU de Limoges, Service de Neurochirurgie, Limoges, France
| | - Nathalie Damon-Perrière
- Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.,CHU de Bordeaux, Service d'explorations Fonctionnelles du Système Nerveux, Bordeaux, France
| | - Dominique Guehl
- Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.,CHU de Bordeaux, Service d'explorations Fonctionnelles du Système Nerveux, Bordeaux, France
| | | | - Nicolas Auzou
- CHU de Bordeaux, Service de Neurologie, Bordeaux, France.,Laboratoire de Psychologie, Université de Bordeaux, Bordeaux, France
| | - François Tison
- Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.,CHU de Bordeaux, Service de Neurologie, Bordeaux, France
| | - Wassilios G Meissner
- Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.,CHU de Bordeaux, Service de Neurologie, Bordeaux, France
| | - Elsa Krim
- CH de Pau, Service de Neurologie, Pau, France
| | | | - Antoine Bénard
- CHU Bordeaux, Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), Bordeaux, France
| | - Rémi Sitta
- CHU Bordeaux, Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), Bordeaux, France
| | - Denys Fontaine
- CHU de Nice, Service de Neurochirurgie, Nice, France.,Université Côte d'Azur, Nice, France
| | - Xavier Hoarau
- Polyclinique de Navarre, Service de Neurochirurgie, Pau, France
| | - Pierre Burbaud
- Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.,CHU de Bordeaux, Service d'explorations Fonctionnelles du Système Nerveux, Bordeaux, France
| | - Emmanuel Cuny
- CHU de Bordeaux, Service de Neurochirurgie B, Bordeaux, France.,Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.,CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France
| |
Collapse
|
9
|
Maltête D, Wallon D, Bourilhon J, Lefaucheur R, Danaila T, Thobois S, Defebvre L, Dujardin K, Houeto JL, Godefroy O, Krystkowiak P, Martinaud O, Gillibert A, Chastan M, Vera P, Hannequin D, Welter ML, Derrey S. Nucleus Basalis of Meynert Stimulation for Lewy Body Dementia: A Phase I Randomized Clinical Trial. Neurology 2020; 96:e684-e697. [PMID: 33199437 DOI: 10.1212/wnl.0000000000011227] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2020] [Accepted: 09/30/2020] [Indexed: 01/29/2023] Open
Abstract
OBJECTIVES Nucleus basalis of Meynert deep brain stimulation (NBM-DBS) has been proposed for patients with dementia. Here, we aim to assess the safety and effects of NBM-DBS in patients with Lewy body dementia (LBD), in a randomized, double-blind, crossover clinical trial. METHODS Six patients with mild to moderate LBD (mean [SD] age, 62.2 [7.8] years) were included, operated on for bilateral NBM-DBS, and assigned to receive either active or sham NBM-DBS followed by the opposite condition for 3 months. The primary outcome was the difference in the total free recalls of the Free and Cued Selective Reminding Test (FCSRT) between active and sham NBM-DBS. Secondary outcomes were assessments of the safety and effects of NBM-DBS on cognition, motor disability, sleep, and PET imaging. RESULTS There was no significant difference in the FCSRT score with active vs sham NBM-DBS. The surgical procedures were well tolerated in all patients, but we observed significant decreases in Stroop and Benton scores after electrode implantation. We observed no significant difference in other scales between active and sham NBM-DBS. With active NBM-DBS relative to baseline, phonemic fluency and motor disability significantly decreased. Lastly, the superior lingual gyrus metabolic activity significantly increased with active NBM-DBS. CONCLUSIONS NBM-DBS does not appear to be totally safe for patients with LBD with no evidence of cognitive benefit. CLINICALTRIALSGOV IDENTIFIER NCT01340001. CLASSIFICATION OF EVIDENCE This study provides Class II evidence that, for patients with LBD operated on for bilateral NBM-DBS, active NBM-DBS stimulation compared to sham stimulation did not significantly change selective recall scores.
Collapse
Affiliation(s)
- David Maltête
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France.
| | - David Wallon
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Julie Bourilhon
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Romain Lefaucheur
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Teodor Danaila
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Stéphane Thobois
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Luc Defebvre
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Kathy Dujardin
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Jean-Luc Houeto
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Olivier Godefroy
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Pierre Krystkowiak
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Olivier Martinaud
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - André Gillibert
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Mathieu Chastan
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Pierre Vera
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Didier Hannequin
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Marie-Laure Welter
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| | - Stéphane Derrey
- From the Departments of Neurology (D.M., D.W., R.L., D.H.), Neurophysiology (J.B., M.-L.W.), and Neurosurgery (S.D.), Rouen University Hospital and University of Rouen; INSERM U1239 (D.M.), Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan; Department of Neurology C (T.D., S.T.), Hopital Neurologique Pierre Wertheimer, University of Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux; Department of Neurology (L.D., K.D.), Lille University Hospital, INSERM 1171; Department of Neurology (J.-L.H.), CIC-INSERM 1402, CHU de Poitiers; Université de Poitiers (J.-L.H.); Department of Neurology (O.G., P.K.), Amiens University Hospital; Department of Neurology (O.M.), Caen University Hospital; Department of Biostatistics (A.G.), Rouen University Hospital; Department of Nuclear Medicine (M.C., P.V.), Henri Becquerel Cancer Center and Rouen University Hospital; and QuantIF-LITIS [EA (Equipe d'Accueil) 4108-FR CNRS 3638] (M.C., P.V.), Faculty of Medicine, University of Rouen, France
| |
Collapse
|
10
|
Santin MDN, Voulleminot P, Vrillon A, Hainque E, Béreau M, Lagha‐Boukbiza O, Wirth T, Montaut S, Bardinet E, Kyheng M, Rolland A, Voirin J, Drapier S, Durif F, Eusebio A, Giordana C, Auzou N, Houeto J, Hubsch C, Jarraya B, Laurencin C, Maltete D, Meyer M, Rascol O, Rouaud T, Tir M, Moreau C, Corvol J, Proust F, Grabli D, Devos D, Tranchant C, Anheim M. Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study. Mov Disord 2020; 36:750-757. [DOI: 10.1002/mds.28320] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2020] [Revised: 09/02/2020] [Accepted: 09/10/2020] [Indexed: 12/17/2022] Open
Affiliation(s)
| | - Paul Voulleminot
- Department of Neurology NS‐PARK/F‐CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg Strasbourg France
| | - Agathe Vrillon
- Department of Neurology NS‐PARK/F‐CRIN, Assistance Publique ‐ Hôpitaux de Paris (APHP), Pitié‐Salpêtrière Hospital Paris France
| | - Elodie Hainque
- Department of Neurology NS‐PARK/F‐CRIN, Assistance Publique ‐ Hôpitaux de Paris (APHP), Pitié‐Salpêtrière Hospital Paris France
- Sorbonne Universités, Assistance Publique ‐ Hôpitaux de Paris (APHP), Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM) Paris France
| | - Matthieu Béreau
- Department of Neurology NS‐PARK/F‐CRIN, University Hospital of Besançon Besançon France
| | - Ouhaid Lagha‐Boukbiza
- Department of Neurology NS‐PARK/F‐CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg Strasbourg France
| | - Thomas Wirth
- Department of Neurology NS‐PARK/F‐CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg Strasbourg France
| | - Solveig Montaut
- Department of Neurology NS‐PARK/F‐CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg Strasbourg France
| | - Eric Bardinet
- Department of Neurology NS‐PARK/F‐CRIN, University Hospital of Besançon Besançon France
- Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle (ICM) Paris France
| | - Maeva Kyheng
- Department of Clinical Research Lille University Hospital Lille France
| | - Anne‐Sophie Rolland
- Department of Medical Pharmacology University Hospital, NS‐PARK/F‐CRIN, University of Lille, Lille Neuroscience & Cognition, Inserm, UMR‐S1172 Lille France
| | - Jimmy Voirin
- Department of Neurosurgery, NS‐PARK/F‐CRIN Strasbourg University Hospital Strasbourg France
| | - Sophie Drapier
- Department of Neurology NS‐PARK/F‐CRIN, University Hospital of Rennes Rennes France
| | - Franck Durif
- Department of Neurology NS‐PARK/F‐CRIN, CHU Clermont‐Ferrand Clermont‐Ferrand France
| | - Alexandre Eusebio
- Department of Neurology NS‐PARK/F‐CRIN, Assistance Publique ‐ Hôpitaux de Marseille (APHM), Timone University Hospital and Institut de Neurosciences de la Timone Marseille France
| | - Caroline Giordana
- Department of Neurology NS‐PARK/F‐CRIN, Centre Hospitalier Universitaire de Nice Nice France
| | - Nicolas Auzou
- Institute of Neurodegenerative Disorders NS‐PARK/F‐CRIN, University Hospital of Bordeaux Bordeaux France
| | - Jean‐Luc Houeto
- Department of Neurology NS‐PARK/F‐CRIN, University Hospital of Poitiers Poitiers France
| | - Cécile Hubsch
- Department of Neurology NS‐PARK/F‐CRIN, Fondation Ophtalmologique Adolphe de Rothschild Paris France
| | - Béchir Jarraya
- Neuroscience Pole NS‐PARK/F‐CRIN, Hôpital Foch, Suresnes, University of Versailles Paris‐Saclay, INSERM‐CEA NeuroSpin Saclay France
| | - Chloé Laurencin
- Department of Neurology NS‐PARK/F‐CRIN, University Hospital of Lyon Lyon France
| | - David Maltete
- Department of Neurology NS‐PARK/F‐CRIN, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication Mont‐Saint‐Aignan France
| | - Mylène Meyer
- Department of Neurology NS‐PARK/F‐CRIN, University Hospital of Nancy Nancy France
| | - Olivier Rascol
- Department of Clinical Pharmacology and Neuroscience NS‐Park/F‐CRIN, Toulouse University Hospital Toulouse France
| | - Tiphaine Rouaud
- Department of Neurology NS‐PARK/F‐CRIN, Nantes University Hospital Nantes France
| | - Mélissa Tir
- Department of Neurology NS‐PARK/FCRIN, Amiens University Hospital Amiens France
| | - Caroline Moreau
- Department of Neurology University Hospital, NS‐PARK/F‐CRIN, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR‐S1172 Lille France
| | - Jean‐Christophe Corvol
- Department of Neurology NS‐PARK/F‐CRIN, Assistance Publique ‐ Hôpitaux de Paris (APHP), Pitié‐Salpêtrière Hospital Paris France
- Sorbonne Universités, Assistance Publique ‐ Hôpitaux de Paris (APHP), Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM) Paris France
| | - François Proust
- Department of Neurosurgery, NS‐PARK/F‐CRIN Strasbourg University Hospital Strasbourg France
| | - David Grabli
- Department of Neurology NS‐PARK/F‐CRIN, Assistance Publique ‐ Hôpitaux de Paris (APHP), Pitié‐Salpêtrière Hospital Paris France
| | - David Devos
- Department of Medical Pharmacology University Hospital, NS‐PARK/F‐CRIN, University of Lille, Lille Neuroscience & Cognition, Inserm, UMR‐S1172 Lille France
- Department of Neurology University Hospital, NS‐PARK/F‐CRIN, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR‐S1172 Lille France
| | - Christine Tranchant
- Department of Neurology NS‐PARK/F‐CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg Strasbourg France
| | - Mathieu Anheim
- Department of Neurology NS‐PARK/F‐CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg Strasbourg France
| | | |
Collapse
|
11
|
Xiao Y, Lau JC, Hemachandra D, Gilmore G, Khan AR, Peters TM. Image Guidance in Deep Brain Stimulation Surgery to Treat Parkinson's Disease: A Comprehensive Review. IEEE Trans Biomed Eng 2020; 68:1024-1033. [PMID: 32746050 DOI: 10.1109/tbme.2020.3006765] [Citation(s) in RCA: 16] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Deep brain stimulation (DBS) is an effective therapy as an alternative to pharmaceutical treatments for Parkinson's disease (PD). Aside from factors such as instrumentation, treatment plans, and surgical protocols, the success of the procedure depends heavily on the accurate placement of the electrode within the optimal therapeutic targets while avoiding vital structures that can cause surgical complications and adverse neurologic effects. Although specific surgical techniques for DBS can vary, interventional guidance with medical imaging has greatly contributed to the development, outcomes, and safety of the procedure. With rapid development in novel imaging techniques, computational methods, and surgical navigation software, as well as growing insights into the disease and mechanism of action of DBS, modern image guidance is expected to further enhance the capacity and efficacy of the procedure in treating PD. This article surveys the state-of-the-art techniques in image-guided DBS surgery to treat PD, and discusses their benefits and drawbacks, as well as future directions on the topic.
Collapse
|
12
|
Maatoug R, Valero-Cabré A, Duriez P, Saudreau B, Fernández-Vidal S, Karachi C, Millet B. Sustained Recovery in a Treatment-Refractory Obsessive-Compulsive Disorder Patient After Deep Brain Stimulation Battery Failure. Front Psychiatry 2020; 11:572059. [PMID: 33281642 PMCID: PMC7691224 DOI: 10.3389/fpsyt.2020.572059] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/12/2020] [Accepted: 09/30/2020] [Indexed: 11/13/2022] Open
Abstract
Obsessive-compulsive disorder (OCD) is a widespread chronic neuropsychiatric disorder characterized by recurrent intrusive thoughts, images, or urges (obsessions) that typically cause anxiety or distress. Even when optimal treatment is provided, 10% of patients remain severely affected chronically. In some countries, deep brain stimulation (DBS) is an approved and effective therapy for patients suffering from treatment-resistant OCD. Hereafter, we report the case of a middle-aged man with a long history of treatment-resistant OCD spanning nearly a decade with Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores oscillating between 21 and 28. The patient underwent bilateral implantation of ventral striatum/ventral capsule DBS leads attached to a battery-operated implanted pulse generator. After a 3-month postimplantation period, the DBS protocol started. Three months after the onset of DBS treatment, the patient's Y-BOCS score had dropped to 3, and he became steadily asymptomatic. However, inadvertently, at this time, it was found out that the implanted pulse generator battery had discharged completely, interrupting brain stimulation. The medical team carried on with the original therapeutic and evaluation plan in the absence of active DBS current. After 12 additional months under off-DBS, the patient remained at a Y-BOCS score of 7 and asymptomatic. To our knowledge, this is the first report that provides an opportunity to discuss four different hypotheses of long-term recovery induced by DBS in a treatment-refractory OCD patient, notably: (1) A placebo effect; (2) Paradoxical improvements induced by micro-lesions generated by DBS probe implantation procedures; (3) Unexpected late spontaneous improvements; (4) Recovery driven by a combination of active DBS-induction, the effects of medication, and DBS-placebo effects.
Collapse
Affiliation(s)
- Redwan Maatoug
- Sorbonne Université, AP-HP, Service de psychiatrie adulte de la Pitié-Salpêtrière, Institut du Cerveau, ICM, Paris, France
| | - Antoni Valero-Cabré
- Groupe de Dynamiques Cérébrales, Plasticité et Rééducation and Frontlab Team, Institut du Cerveau (ICM), INSERM 1127, CNRS, UMR 7225 and Sorbonne Université (SO), Paris, France.,Institut du Cerveau et de la Moelle Epinière (ICM), CNRS UMR 7225, INSERM U 1127, Sorbonne Université, Paris, France.,Laboratory for Cerebral Dynamics Plasticity and Rehabilitation, Boston University, School of Medicine, Boston, MA, United States.,Cognitive Neuroscience and Information Technology Research Program, Open University of Catalonia (UOC), Barcelona, Spain
| | - Philibert Duriez
- Institute of Psychiatry and Neurosciences of Paris, Unité Mixte de Recherche en Santé (UMRS) 1266 Institut National de la Santé et de la Recherche Médicale (INSERM), University Paris Descartes, Paris, France.,Clinique des Maladies Mentales et de l'Encéphale, Groupement Hospitalier Universitaire (GHU) Paris Psychiatry and Neuroscience, Sainte-Anne Hospital, Paris, France
| | - Bertrand Saudreau
- Sorbonne Université, AP-HP, Service de psychiatrie adulte de la Pitié-Salpêtrière, Institut du Cerveau, ICM, Paris, France
| | - Sara Fernández-Vidal
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau (CRICM), UMR-S975, Paris, France.,INSERM, U975, Paris, France.,CNRS, UMR 7225, CR-ICM, Paris, France.,Centre de Neuroimagerie de Recherche de l'Institut du Cerveau (CENIR ICM), Paris, France
| | - Carine Karachi
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau (CRICM), UMR-S975, Paris, France.,INSERM, U975, Paris, France.,CNRS, UMR 7225, CR-ICM, Paris, France.,Neurosurgery Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - Bruno Millet
- Sorbonne Université, AP-HP, Service de psychiatrie adulte de la Pitié-Salpêtrière, Institut du Cerveau, ICM, Paris, France
| |
Collapse
|
13
|
The anatomo-functional organization of the hyperdirect cortical pathway to the subthalamic area using in vivo structural connectivity imaging in humans. Brain Struct Funct 2019; 225:551-565. [DOI: 10.1007/s00429-019-02012-6] [Citation(s) in RCA: 17] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/25/2019] [Accepted: 12/12/2019] [Indexed: 12/20/2022]
|
14
|
Rozier C, Seidel Malkinson T, Hasboun D, Baulac M, Adam C, Lehongre K, Clémenceau S, Navarro V, Naccache L. Conscious and unconscious expectancy effects: A behavioral, scalp and intracranial electroencephalography study. Clin Neurophysiol 2019; 131:385-400. [PMID: 31865140 DOI: 10.1016/j.clinph.2019.10.024] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2019] [Revised: 09/04/2019] [Accepted: 10/16/2019] [Indexed: 11/29/2022]
Abstract
OBJECTIVE The scope of unconscious cognition stretched its limits dramatically during the last 40 years, yet most unconscious processes and representations that have been described so far are fleeting and very short-lived, whereas conscious representations can be actively maintained in working memory for a virtually unlimited period. In the present work we aimed at exploring conscious and unconscious lasting (>1 second) expectancy effects. METHODS In a series of four experiments we engaged participants in the foreperiod paradigm while using both unmasked and masked cues that were informative about the presence/absence of an upcoming target. We recorded behavioral responses, high-density scalp EEG (Exp. 2a), and intra-cranial EEG (Exp. 2b). RESULTS While conscious expectancy was associated with a large behavioral effect (~150 ms), unconscious expectancy effect was significant but much smaller (4 ms). Both conscious and unconscious expectancy Contingent Negative Variations (CNVs) originated from temporal cortices, but only the late component of conscious CNV originated from an additional source located in the vicinity of mesio-frontal areas and supplementary motor areas. Finally, only conscious expectancy was accessible to introspection. CONCLUSIONS Both unmasked and masked cues had an impact on response times and on brain activity. SIGNIFICANCE These results support a two-stage model of the underlying mechanisms of expectancy.
Collapse
Affiliation(s)
- Camille Rozier
- Sorbonne Université, UPMC Univ Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France; INSERM, U 1127, F-75013 Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, PICNIC Lab, F-75013 Paris, France
| | - Tal Seidel Malkinson
- Sorbonne Université, UPMC Univ Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France; INSERM, U 1127, F-75013 Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, PICNIC Lab, F-75013 Paris, France
| | - Dominique Hasboun
- Sorbonne Université, UPMC Univ Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France
| | - Michel Baulac
- Sorbonne Université, UPMC Univ Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurology, Paris, France
| | - Claude Adam
- AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurology, Paris, France
| | - Katia Lehongre
- Institut du Cerveau et de la Moelle épinière, CENIR, Paris, France
| | - Stéphane Clémenceau
- AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurosurgery, Paris, France
| | - Vincent Navarro
- Sorbonne Université, UPMC Univ Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France; INSERM, U 1127, F-75013 Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, PICNIC Lab, F-75013 Paris, France; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurology, Paris, France; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurophysiology, Paris, France
| | - Lionel Naccache
- Sorbonne Université, UPMC Univ Paris 06, Faculté de Médecine Pitié-Salpêtrière, Paris, France; INSERM, U 1127, F-75013 Paris, France; Institut du Cerveau et de la Moelle épinière, ICM, PICNIC Lab, F-75013 Paris, France; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurology, Paris, France; AP-HP, Groupe hospitalier Pitié-Salpêtrière, Department of Neurophysiology, Paris, France.
| |
Collapse
|
15
|
Pyatigorskaya N, Yahia‐Cherif L, Gaurav R, Ewenczyk C, Gallea C, Valabregue R, Gargouri F, Magnin B, Degos B, Roze E, Bardinet E, Poupon C, Arnulf I, Vidailhet M, Lehericy S. Multimodal Magnetic Resonance Imaging Quantification of Brain Changes in Progressive Supranuclear Palsy. Mov Disord 2019; 35:161-170. [DOI: 10.1002/mds.27877] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2019] [Revised: 08/17/2019] [Accepted: 09/15/2019] [Indexed: 12/11/2022] Open
Affiliation(s)
- Nadya Pyatigorskaya
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
- Service de Neuroradiologie, APHP, Hôpital Pitié‐Salpêtrière Paris France
| | - Lydia Yahia‐Cherif
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
| | - Rahul Gaurav
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
| | - Claire Ewenczyk
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
- Clinique des mouvements anormaux, Département des Maladies du Système Nerveux Hôpital Pitié‐Salpêtrière, APHP Paris France
| | - Cecile Gallea
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
| | - Romain Valabregue
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
| | - Fatma Gargouri
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
| | - Benoit Magnin
- Service de Radiologie, CHU Clermont‐Ferrand Clermont‐Ferrand France
| | - Bertrand Degos
- Service de Neurologie, Hôpital Avicenne, APHP Bobigny France
| | - Emmanuel Roze
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
- Clinique des mouvements anormaux, Département des Maladies du Système Nerveux Hôpital Pitié‐Salpêtrière, APHP Paris France
| | - Eric Bardinet
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
| | | | - Isabelle Arnulf
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
- Service de pathologies du Sommeil, Hôpital Pitié‐Salpêtrière, APHP Paris France
| | - Marie Vidailhet
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
- Clinique des mouvements anormaux, Département des Maladies du Système Nerveux Hôpital Pitié‐Salpêtrière, APHP Paris France
| | - Stéphane Lehericy
- Institut du Cerveau et de la Moelle–ICM, Centre de NeuroImagerie de Recherche–CENIR Paris France
- ICM, Sorbonne Université, UPMC Univ Paris 06 UMR S 1127, CNRS UMR 7225 Paris France
- Service de Neuroradiologie, APHP, Hôpital Pitié‐Salpêtrière Paris France
| |
Collapse
|
16
|
Marchal V, Sellers J, Pélégrini-Issac M, Galléa C, Bertasi E, Valabrègue R, Lau B, Leboucher P, Bardinet E, Welter ML, Karachi C. Deep brain activation patterns involved in virtual gait without and with a doorway: An fMRI study. PLoS One 2019; 14:e0223494. [PMID: 31634356 PMCID: PMC6802850 DOI: 10.1371/journal.pone.0223494] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/22/2019] [Accepted: 09/22/2019] [Indexed: 11/23/2022] Open
Abstract
The human gait program involves many brain areas such as motor cortices, cerebellum, basal ganglia, brainstem, and spinal cord. The mesencephalic locomotor region (MLR), which contains the pedunculopontine (PPN) and cuneiform (CN) nuclei, is thought to be one of the key supraspinal gait generators. In daily life activities, gait primarily occurs in complex conditions, such as through narrow spaces, or while changing direction or performing motor or cognitive tasks. Here, we aim to explore the activity of these subcortical brain areas while walking through narrow spaces, using functional MRI in healthy volunteers and designing a virtual reality task mimicking walking down a hallway, without and with an open doorway to walk through. As a control, we used a virtual moving walkway in the same environment. Twenty healthy volunteers were scanned. Fifteen subjects were selected for second level analysis based on their ability to activate motor cortices. Using the contrast Gait versus Walkway, we found activated clusters in motor cortices, cerebellum, red nucleus, thalamus, and the left MLR including the CN and PPN. Using the contrast Gait with Doorway versus Walkway with Doorway, we found activated clusters in motor cortices, left putamen, left internal pallidum, left substantia nigra, right subthalamic area, and bilateral MLR involving the CN and PPN. Our results suggest that unobstructed gait involves a motor network including the PPN whereas gait through a narrow space requires the additional participation of basal ganglia and bilateral MLR, which may encode environmental cues to adapt locomotion.
Collapse
Affiliation(s)
- Véronique Marchal
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
| | - Jason Sellers
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
| | | | - Cécile Galléa
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
| | - Eric Bertasi
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
- Centre de Neuroimagerie de recherche (CENIR), ICM, Paris, France
| | - Romain Valabrègue
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
- Centre de Neuroimagerie de recherche (CENIR), ICM, Paris, France
| | - Brian Lau
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
| | - Pierre Leboucher
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
- Plateforme PRISME, ICM, Paris, France
| | - Eric Bardinet
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
- Centre de Neuroimagerie de recherche (CENIR), ICM, Paris, France
- * E-mail:
| | - Marie-Laure Welter
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
- Service de Neurophysiologie, CHU Rouen, Université de Rouen, Rouen, France
| | - Carine Karachi
- Sorbonne Universités, UPMC Univ Paris, CNRS, INSERM, AP HP GH Pitié Salpêtrière, Institut du Cerveau et de la Moelle épinière (ICM), Paris, France
- Service de Neurochirurgie, AP-HP, GH Pitié-Salpêtrière, Paris, France
| |
Collapse
|
17
|
Lemaire JJ, De Salles A, Coll G, El Ouadih Y, Chaix R, Coste J, Durif F, Makris N, Kikinis R. MRI Atlas of the Human Deep Brain. Front Neurol 2019; 10:851. [PMID: 31507507 PMCID: PMC6718608 DOI: 10.3389/fneur.2019.00851] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2019] [Accepted: 07/23/2019] [Indexed: 12/15/2022] Open
Abstract
Mastering detailed anatomy of the human deep brain in clinical neurosciences is challenging. Although numerous pioneering works have gathered a large dataset of structural and topographic information, it is still difficult to transfer this knowledge into practice, even with advanced magnetic resonance imaging techniques. Thus, classical histological atlases continue to be used to identify structures for stereotactic targeting in functional neurosurgery. Physicians mainly use these atlases as a template co-registered with the patient's brain. However, it is possible to directly identify stereotactic targets on MRI scans, enabling personalized targeting. In order to help clinicians directly identify deep brain structures relevant to present and future medical applications, we built a volumetric MRI atlas of the deep brain (MDBA) on a large scale (infra millimetric). Twelve hypothalamic, 39 subthalamic, 36 telencephalic, and 32 thalamic structures were identified, contoured, and labeled. Nineteen coronal, 18 axial, and 15 sagittal MRI plates were created. Although primarily designed for direct labeling, the anatomic space was also subdivided in twelfths of AC-PC distance, leading to proportional scaling in the coronal, axial, and sagittal planes. This extensive work is now available to clinicians and neuroscientists, offering another representation of the human deep brain ([https://hal.archives-ouvertes.fr/] [hal-02116633]). The atlas may also be used by computer scientists who are interested in deciphering the topography of this complex region.
Collapse
Affiliation(s)
- Jean-Jacques Lemaire
- Service de Neurochirurgie, CHU Clermont-Ferrand, Université Clermont Auvergne, Centre National de la Recherche Scientifique, Engineering School SIGMA Clermont, Clermont-Ferrand, France
| | - Antonio De Salles
- Department of Neurosurgery, Radiation Oncology, HCOR Neuroscience, São Paulo, Brazil
| | - Guillaume Coll
- Service de Neurochirurgie, CHU Clermont-Ferrand, Université Clermont Auvergne, Centre National de la Recherche Scientifique, Engineering School SIGMA Clermont, Clermont-Ferrand, France
| | - Youssef El Ouadih
- Service de Neurochirurgie, CHU Clermont-Ferrand, Université Clermont Auvergne, Centre National de la Recherche Scientifique, Engineering School SIGMA Clermont, Clermont-Ferrand, France
| | - Rémi Chaix
- Service de Neurochirurgie, CHU Clermont-Ferrand, Université Clermont Auvergne, Centre National de la Recherche Scientifique, Engineering School SIGMA Clermont, Clermont-Ferrand, France
| | - Jérôme Coste
- Service de Neurochirurgie, CHU Clermont-Ferrand, Université Clermont Auvergne, Centre National de la Recherche Scientifique, Engineering School SIGMA Clermont, Clermont-Ferrand, France
| | - Franck Durif
- Service de Neurologie, Centre National de la Recherche Scientifique, CHU Clermont-Ferrand, Université Clermont Auvergne, Engineering School SIGMA Clermont, Clermont-Ferrand, France
| | - Nikos Makris
- Surgical Planning Laboratory, Center for Morphometric Analysis, A. Martinos Center for Biomedical Imaging, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA, United States
| | - Ron Kikinis
- Surgical Planning Laboratory, Center for Morphometric Analysis, A. Martinos Center for Biomedical Imaging, Harvard Medical School, Massachusetts General Hospital, Brigham and Women's Hospital, Boston, MA, United States.,Robert Greenes Distinguished Director of Biomedical Informatics, Brigham and Women's Hospital, Boston, MA, United States.,Computer Science Department, Fraunhofer MEVIS, University of Bremen, Bremen, Germany
| |
Collapse
|
18
|
Levy J, Facchinetti P, Jan C, Achour M, Bouvier C, Brunet JF, Delzescaux T, Giuliano F. Tridimensional mapping of Phox2b expressing neurons in the brainstem of adult Macaca fascicularis and identification of the retrotrapezoid nucleus. J Comp Neurol 2019; 527:2875-2884. [PMID: 31071232 DOI: 10.1002/cne.24713] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2019] [Revised: 04/29/2019] [Accepted: 04/29/2019] [Indexed: 11/08/2022]
Abstract
Chemosensitivity is a key mechanism for the regulation of breathing in vertebrates. The retrotrapezoid nucleus is a crucial hub for respiratory chemoreception within the brainstem. It integrates chemosensory information that are both peripheral from the carotid bodies (via the nucleus of the solitary tract) and central through the direct sensing of extracellular protons. To date, the location of a genetically defined RTN has only been ascertained in rodents. We first demonstrated that Phox2b, a key determinant for the development of the visceral nervous system and branchiomotor nuclei in the brainstem including the RTN, had a similar distribution in the brainstem of adult macaques compared to adult rats. Second, based on previous description of a specific molecular signature for the RTN in rats, and on an innovative technique for duplex in situ hybridization, we identified parafacial neurons which coexpressed Phox2b and ppGal mRNAs. They were located ventrally to the nucleus of the facial nerve and extended from the caudal part of the nucleus of the superior olive to the rostral tip of the inferior olive. Using the previously described blockface technique, deformations were corrected to allow the proper alignment and stacking of digitized sections, hence providing for the first time a 3D reconstruction of the macaque brainstem, Phox2b distribution and the primate retrotrapezoid nucleus. This description should help bridging the gap between rodents and humans for the description of key respiratory structures in the brainstem.
Collapse
Affiliation(s)
- Jonathan Levy
- INSERM UMR1179-Handicap Neuromusculaire, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.,Service de Médecine Physique et de Réadaptation-APHP, Hôpital Raymond Poincaré, Garches, France.,Fondation Garches-APHP, Hôpital Raymond Poincaré, Garches, France
| | - Patricia Facchinetti
- INSERM UMR1179-Handicap Neuromusculaire, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
| | - Caroline Jan
- Molecular Imaging Research Center (MIRCen)-Commissariat à l'Énergie Atomique (CEA), Fontenay-aux-Roses, France.,CNRS-CEA UMR9199-Neurodegenerative Diseases Laboratory, Université Paris-Saclay, Fontenay-aux-Roses, France
| | - Mélyna Achour
- INSERM UMR1179-Handicap Neuromusculaire, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France
| | - Clément Bouvier
- Molecular Imaging Research Center (MIRCen)-Commissariat à l'Énergie Atomique (CEA), Fontenay-aux-Roses, France.,NEOXIA, Paris, France
| | - Jean-François Brunet
- Institut de Biologie de l'Ecole Normale Supérieure (IBENS), Ecole normale supérieure, CNRS, INSERM, PSL Université, Paris, France
| | - Thierry Delzescaux
- Molecular Imaging Research Center (MIRCen)-Commissariat à l'Énergie Atomique (CEA), Fontenay-aux-Roses, France.,CNRS-CEA UMR9199-Neurodegenerative Diseases Laboratory, Université Paris-Saclay, Fontenay-aux-Roses, France
| | - François Giuliano
- INSERM UMR1179-Handicap Neuromusculaire, Université de Versailles Saint-Quentin-en-Yvelines, Montigny-le-Bretonneux, France.,Service de Médecine Physique et de Réadaptation-APHP, Hôpital Raymond Poincaré, Garches, France
| |
Collapse
|
19
|
Karachi C, Cormier-Dequaire F, Grabli D, Lau B, Belaid H, Navarro S, Vidailhet M, Bardinet E, Fernandez-Vidal S, Welter ML. Clinical and anatomical predictors for freezing of gait and falls after subthalamic deep brain stimulation in Parkinson's disease patients. Parkinsonism Relat Disord 2019; 62:91-97. [PMID: 30704853 DOI: 10.1016/j.parkreldis.2019.01.021] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2018] [Revised: 01/22/2019] [Accepted: 01/23/2019] [Indexed: 10/27/2022]
Abstract
INTRODUCTION Freezing of gait (FOG) and falls are the most disabling motor symptoms in Parkinson's disease (PD) patients. The effects of subthalamic deep-brain-stimulation (STN-DBS) on FOG and falls are still a matter of controversy, and factors contributing to their outcome have yet to be defined. METHODS We examined the relationship between FOG and falls after STN-DBS and preoperative clinical features, MRI voxel-based-morphometry (VBM) analysis and statistical mapping of electrode locations. RESULTS 331 patients (age at surgery = 57.7 ± 8.4 years; disease duration = 12.5 ± 5 years) were included in the final analysis, with VBM analysis in 151 patients. After surgery, FOG was aggravated in 93 patients and falls in 75 patients. After surgery, FOG severity was related to its level before surgery without dopaminergic treatment, the dopaminergic treatment dosage and severity of motor fluctuations after surgery; and falls severity to lower postoperative cognitive performance. VBM analyses revealed that, relative to other patient groups, patients with FOG worsening had putamen grey matter density decrease, and fallers patients a left postcentral gyrus atrophy. The best effects of STN-DBS on FOG and falls were associated with the location of contacts within the STN, but no specific location related to aggravation. CONCLUSIONS FOG and falls are reduced after STN-DBS in about 1/3 of patients, with the best effects obtained for electrodes located within the STN. Clinicians should be aware that, after STN-DBS, FOG severity is related to preoperative FOG severity whatever its dopa-sensitivity; and falls to lower postoperative cognitive performance; and atrophy of cortico-subcortical brain areas.
Collapse
Affiliation(s)
- Carine Karachi
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Neurosurgery Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - Florence Cormier-Dequaire
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Neurology Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - David Grabli
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Neurology Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - Brian Lau
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France
| | - Hayat Belaid
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Neurosurgery Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - Soledad Navarro
- Neurosurgery Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - Marie Vidailhet
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Neurology Department, APHP, Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France
| | - Eric Bardinet
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Centre de Neuroimagerie de Recherche de l'Institut du Cerveau et de la Moelle épinière (CENIR ICM), Paris, France
| | - Sara Fernandez-Vidal
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Centre de Neuroimagerie de Recherche de l'Institut du Cerveau et de la Moelle épinière (CENIR ICM), Paris, France
| | - Marie-Laure Welter
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France; INSERM, U975, Paris, France; CNRS, UMR 7225, CR-ICM, Paris, France; Neurophysiology Department, CHU Rouen, Normandie University, Rouen, France.
| |
Collapse
|
20
|
Sébille SB, Rolland AS, Faillot M, Perez-Garcia F, Colomb-Clerc A, Lau B, Dumas S, Vidal SF, Welter ML, Francois C, Bardinet E, Karachi C. Normal and pathological neuronal distribution of the human mesencephalic locomotor region. Mov Disord 2018; 34:218-227. [PMID: 30485555 DOI: 10.1002/mds.27578] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2018] [Revised: 06/10/2018] [Accepted: 10/22/2018] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Deep brain stimulation of the pedunculopontine nucleus has been performed to treat dopamine-resistant gait and balance disorders in patients with degenerative diseases. The outcomes, however, are variable, which may be the result of the lack of a well-defined anatomical target. OBJECTIVES The objectives of this study were to identify the main neuronal populations of the pedunculopontine and the cuneiform nuclei that compose the human mesencephalic locomotor region and to compare their 3-dimensional distribution with those found in patients with Parkinson's disease and progressive supranuclear palsy. METHODS We used high-field MRI, immunohistochemistry, and in situ hybridization to characterize the distribution of the different cell types, and we developed software to merge all data within a common 3-dimensional space. RESULTS We found that cholinergic, GABAergic, and glutamatergic neurons comprised the main cell types of the mesencephalic locomotor region, with the peak densities of cholinergic and GABAergic neurons similarly located within the rostral pedunculopontine nucleus. Cholinergic and noncholinergic neuronal losses were homogeneous in the mesencephalic locomotor region of patients, with the peak density of remaining neurons at the same location as in controls. The degree of denervation of the pedunculopontine nucleus was highest in patients with progressive supranuclear palsy, followed by Parkinson's disease patients with falls. CONCLUSIONS The peak density of cholinergic and GABAergic neurons was located similarly within the rostral pedunculopontine nucleus not only in controls but also in pathological cases. The neuronal loss was homogeneously distributed and highest in the pedunculopontine nucleus of patients with falls, which suggests a potential pathophysiological link. © 2018 International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Sophie B Sébille
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France.,Centre de Neuro-Imagerie de Recherche, Paris, France
| | - Anne-Sophie Rolland
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France
| | - Matthieu Faillot
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France.,Neurosurgical Department, La Pitié-Salpêtrière University Hospital, Paris, France
| | | | - Antoine Colomb-Clerc
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France
| | - Brian Lau
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France
| | | | | | - Marie-Laure Welter
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France.,Neurosurgical Department, La Pitié-Salpêtrière University Hospital, Paris, France
| | - Chantal Francois
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France
| | - Eric Bardinet
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France.,Centre de Neuro-Imagerie de Recherche, Paris, France
| | - Carine Karachi
- Sorbonne University, Univ. Pierre & Marie Curie Paris 06, Cnrs, Inserm, AP-HP Pitié-Salpêtrière hospital, Brain and Spinal Cord Institute, Paris, France.,Neurosurgical Department, La Pitié-Salpêtrière University Hospital, Paris, France
| |
Collapse
|
21
|
Güngör A, Baydın ŞS, Holanda VM, Middlebrooks EH, Isler C, Tugcu B, Foote K, Tanriover N. Microsurgical anatomy of the subthalamic nucleus: correlating fiber dissection results with 3-T magnetic resonance imaging using neuronavigation. J Neurosurg 2018; 130:716-732. [PMID: 29726781 DOI: 10.3171/2017.10.jns171513] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2017] [Accepted: 10/18/2017] [Indexed: 02/06/2023]
Abstract
OBJECTIVE Despite the extensive use of the subthalamic nucleus (STN) as a deep brain stimulation (DBS) target, unveiling the extensive functional connectivity of the nucleus, relating its structural connectivity to the stimulation-induced adverse effects, and thus optimizing the STN targeting still remain challenging. Mastering the 3D anatomy of the STN region should be the fundamental goal to achieve ideal surgical results, due to the deep-seated and obscure position of the nucleus, variable shape and relatively small size, oblique orientation, and extensive structural connectivity. In the present study, the authors aimed to delineate the 3D anatomy of the STN and unveil the complex relationship between the anatomical structures within the STN region using fiber dissection technique, 3D reconstructions of high-resolution MRI, and fiber tracking using diffusion tractography utilizing a generalized q-sampling imaging (GQI) model. METHODS Fiber dissection was performed in 20 hemispheres and 3 cadaveric heads using the Klingler method. Fiber dissections of the brain were performed from all orientations in a stepwise manner to reveal the 3D anatomy of the STN. In addition, 3 brains were cut into 5-mm coronal, axial, and sagittal slices to show the sectional anatomy. GQI data were also used to elucidate the connections among hubs within the STN region. RESULTS The study correlated the results of STN fiber dissection with those of 3D MRI reconstruction and tractography using neuronavigation. A 3D terrain model of the subthalamic area encircling the STN was built to clarify its anatomical relations with the putamen, globus pallidus internus, globus pallidus externus, internal capsule, caudate nucleus laterally, substantia nigra inferiorly, zona incerta superiorly, and red nucleus medially. The authors also describe the relationship of the medial lemniscus, oculomotor nerve fibers, and the medial forebrain bundle with the STN using tractography with a 3D STN model. CONCLUSIONS This study examines the complex 3D anatomy of the STN and peri-subthalamic area. In comparison with previous clinical data on STN targeting, the results of this study promise further understanding of the structural connections of the STN, the exact location of the fiber compositions within the region, and clinical applications such as stimulation-induced adverse effects during DBS targeting.
Collapse
Affiliation(s)
- Abuzer Güngör
- 1Department of Neurosurgery, Acıbadem University
- 2Department of Neurosurgery, Bakirkoy Research & Training Hospital for Psychiatry, Neurology, and Neurosurgery
| | - Şevki Serhat Baydın
- 3Department of Neurosurgery, Kanuni Sultan Süleyman Research & Training Hospital
| | - Vanessa M Holanda
- 4Department of Neurosurgery, University of Florida, Gainesville, Florida; and
| | | | - Cihan Isler
- 6Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
| | - Bekir Tugcu
- 2Department of Neurosurgery, Bakirkoy Research & Training Hospital for Psychiatry, Neurology, and Neurosurgery
| | - Kelly Foote
- 4Department of Neurosurgery, University of Florida, Gainesville, Florida; and
| | - Necmettin Tanriover
- 6Department of Neurosurgery, Cerrahpasa Medical Faculty, Istanbul University, Istanbul, Turkey
| |
Collapse
|
22
|
Pichat J, Iglesias JE, Yousry T, Ourselin S, Modat M. A Survey of Methods for 3D Histology Reconstruction. Med Image Anal 2018; 46:73-105. [DOI: 10.1016/j.media.2018.02.004] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2017] [Revised: 02/02/2018] [Accepted: 02/14/2018] [Indexed: 02/08/2023]
|
23
|
Milchenko M, Norris SA, Poston K, Campbell MC, Ushe M, Perlmutter JS, Snyder AZ. 7T MRI subthalamic nucleus atlas for use with 3T MRI. J Med Imaging (Bellingham) 2018; 5:015002. [PMID: 29340288 DOI: 10.1117/1.jmi.5.1.015002] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2017] [Accepted: 12/12/2017] [Indexed: 12/13/2022] Open
Abstract
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) reduces motor symptoms in most patients with Parkinson disease (PD), yet may produce untoward effects. Investigation of DBS effects requires accurate localization of the STN, which can be difficult to identify on magnetic resonance images collected with clinically available 3T scanners. The goal of this study is to develop a high-quality STN atlas that can be applied to standard 3T images. We created a high-definition STN atlas derived from seven older participants imaged at 7T. This atlas was nonlinearly registered to a standard template representing 56 patients with PD imaged at 3T. This process required development of methodology for nonlinear multimodal image registration. We demonstrate mm-scale STN localization accuracy by comparison of our 3T atlas with a publicly available 7T atlas. We also demonstrate less agreement with an earlier histological atlas. STN localization error in the 56 patients imaged at 3T was less than 1 mm on average. Our methodology enables accurate STN localization in individuals imaged at 3T. The STN atlas and underlying 3T average template in MNI space are freely available to the research community. The image registration methodology developed in the course of this work may be generally applicable to other datasets.
Collapse
Affiliation(s)
- Mikhail Milchenko
- Washington University in St. Louis School of Medicine, Mallinckgrodt Institute of Radiology, St. Louis, Missouri, United States
| | - Scott A Norris
- Washington University in St. Louis School of Medicine, Department of Neurology, St. Louis, Missouri, United States
| | - Kathleen Poston
- Stanford University Medical Center, Department of Neurology & Neurological Sciences, Palo Alto, California, United States
| | - Meghan C Campbell
- Washington University in St. Louis School of Medicine, Department of Neurology, St. Louis, Missouri, United States
| | - Mwiza Ushe
- Washington University in St. Louis School of Medicine, Department of Neurology, St. Louis, Missouri, United States
| | - Joel S Perlmutter
- Washington University in St. Louis School of Medicine, Department of Neurology, St. Louis, Missouri, United States
| | - Abraham Z Snyder
- Washington University in St. Louis School of Medicine, Mallinckgrodt Institute of Radiology, St. Louis, Missouri, United States.,Washington University in St. Louis School of Medicine, Department of Neurology, St. Louis, Missouri, United States
| |
Collapse
|
24
|
Bourlon C, Urbanski M, Quentin R, Duret C, Bardinet E, Bartolomeo P, Bourgeois A. Cortico-thalamic disconnection in a patient with supernumerary phantom limb. Exp Brain Res 2017; 235:3163-3174. [PMID: 28752330 DOI: 10.1007/s00221-017-5044-y] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Accepted: 07/20/2017] [Indexed: 11/24/2022]
Abstract
Supernumerary phantom limb (SPL) designates the experience of an illusory additional limb occurring after brain damage. Functional neuroimaging during SPL movements documented increased response in the ipsilesional supplementary motor area (SMA), premotor cortex (PMC), thalamus and caudate. This suggested that motor circuits are important for bodily related cognition, but anatomical evidence is sparse. Here, we tested this hypothesis by studying an extremely rare patient with chronic SPL, still present 3 years after a vascular stroke affecting cortical and subcortical right-hemisphere structures. Anatomical analysis included an advanced in vivo reconstruction of white matter tracts using diffusion-based spherical deconvolution. This reconstruction demonstrated a massive and relatively selective disconnection between anatomically preserved SMA/PMC and the thalamus. Our results provide strong anatomical support for the hypothesis that cortico-thalamic loops involving motor-related circuits are crucial to integrate sensorimotor processing with bodily self-awareness.
Collapse
Affiliation(s)
- Clémence Bourlon
- Unité de Neurorééducation, Centre de Rééducation Fonctionnelle Les Trois Soleils, 77310, Boissise Le Roi, France. .,Service de Médecine et de Réadaptation gériatrique et neurologique, Hôpitaux de Saint-Maurice, 94410, Saint-Maurice, France. .,Inserm U1127, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, Brain and Spine Institute, Groupe Hospitalier Pitié-Salpêtrière, 75013, Paris, France.
| | - Marika Urbanski
- Service de Médecine et de Réadaptation gériatrique et neurologique, Hôpitaux de Saint-Maurice, 94410, Saint-Maurice, France.,Inserm U1127, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, Brain and Spine Institute, Groupe Hospitalier Pitié-Salpêtrière, 75013, Paris, France
| | - Romain Quentin
- National Institute of Neurological Disorders and Stroke (NINDS), Bethesda, MD, USA
| | - Christophe Duret
- Unité de Neurorééducation, Centre de Rééducation Fonctionnelle Les Trois Soleils, 77310, Boissise Le Roi, France.,Centre Hospitalier Sud Francilien, Neurologie, 91100, Corbeil-Essonnes, France
| | - Eric Bardinet
- Centre de NeuroImagerie de Recherche-CENIR, Institut du Cerveau et de la Moelle épinière-ICM, 75013, Paris, France
| | - Paolo Bartolomeo
- Inserm U1127, Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, Brain and Spine Institute, Groupe Hospitalier Pitié-Salpêtrière, 75013, Paris, France
| | - Alexia Bourgeois
- Laboratory for Behavioral Neurology and Imaging of Cognition, Neuroscience Department, University of Geneva, Geneva, Switzerland
| |
Collapse
|
25
|
Santin MD, Didier M, Valabrègue R, Yahia Cherif L, García-Lorenzo D, Loureiro de Sousa P, Bardinet E, Lehéricy S. Reproducibility of R 2 * and quantitative susceptibility mapping (QSM) reconstruction methods in the basal ganglia of healthy subjects. NMR IN BIOMEDICINE 2017; 30:e3491. [PMID: 26913373 DOI: 10.1002/nbm.3491] [Citation(s) in RCA: 41] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/16/2015] [Revised: 12/15/2015] [Accepted: 12/31/2015] [Indexed: 06/05/2023]
Abstract
The basal ganglia are key structures for motor, cognitive and behavioral functions. They undergo several changes with aging and disease, such as Parkinson's or Huntington's disease, for example. Iron accumulation in basal ganglia is often related to these diseases, which is conventionally monitored by the transverse relaxation rate (R2 *). Quantitative susceptibility mapping (QSM) is a novel contrast mechanism in MRI produced by adding information taken from the phase of the MR signal to its magnitude. It has been shown to be more sensitive to subtle changes in Parkinson's disease. In order to be applied widely to various pathologies, its reproducibility must be evaluated in order to assess intra-subject variability and to disseminate into clinical and pharmaceutical studies. In this work, we studied the reproducibility and sensitivity of several QSM techniques. Fourteen subjects were scanned four times, and QSM and R2 * images were reconstructed and registered. An atlas of the basal ganglia was used to automatically define regions of interest. We found that QSM measurements are indeed reproducible in the basal ganglia of healthy subjects and can be widely used as a replacement for R2 * mapping in iron-rich regions. This reproducibility study could lead to several lines of research in relaxometry and susceptibility measurements, in vivo iron load evaluation as well as pharmacological assessment and biomarker development. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- M D Santin
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| | - M Didier
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| | - R Valabrègue
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| | - L Yahia Cherif
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| | - D García-Lorenzo
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| | | | - E Bardinet
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| | - S Lehéricy
- CENIR, Centre de NeuroImagerie de Recherche, Paris, France
- ICM, Inserm U 1127, CNRS UMR 7225, Sorbonne Universités, UPMC Université Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, Paris, France
| |
Collapse
|
26
|
Pujol S, Cabeen R, Sébille SB, Yelnik J, François C, Fernandez Vidal S, Karachi C, Zhao Y, Cosgrove GR, Jannin P, Kikinis R, Bardinet E. In vivo Exploration of the Connectivity between the Subthalamic Nucleus and the Globus Pallidus in the Human Brain Using Multi-Fiber Tractography. Front Neuroanat 2017; 10:119. [PMID: 28154527 PMCID: PMC5243825 DOI: 10.3389/fnana.2016.00119] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2016] [Accepted: 11/25/2016] [Indexed: 11/13/2022] Open
Abstract
The basal ganglia is part of a complex system of neuronal circuits that play a key role in the integration and execution of motor, cognitive and emotional function in the human brain. Parkinson’s disease is a progressive neurological disorder of the motor circuit characterized by tremor, rigidity, and slowness of movement. Deep brain stimulation (DBS) of the subthalamic nucleus and the globus pallidus pars interna provides an efficient treatment to reduce symptoms and levodopa-induced side effects in Parkinson’s disease patients. While the underlying mechanism of action of DBS is still unknown, the potential modulation of white matter tracts connecting the surgical targets has become an active area of research. With the introduction of advanced diffusion MRI acquisition sequences and sophisticated post-processing techniques, the architecture of the human brain white matter can be explored in vivo. The goal of this study is to investigate the white matter connectivity between the subthalamic nucleus and the globus pallidus. Two multi-fiber tractography methods were used to reconstruct pallido-subthalamic, subthalamo-pallidal and pyramidal fibers in five healthy subjects datasets of the Human Connectome Project. The anatomical accuracy of the tracts was assessed by four judges with expertise in neuroanatomy, functional neurosurgery, and diffusion MRI. The variability among subjects was evaluated based on the fractional anisotropy and mean diffusivity of the tracts. Both multi-fiber approaches enabled the detection of complex fiber architecture in the basal ganglia. The qualitative evaluation by experts showed that the identified tracts were in agreement with the expected anatomy. Tract-derived measurements demonstrated relatively low variability among subjects. False-negative tracts demonstrated the current limitations of both methods for clinical decision-making. Multi-fiber tractography methods combined with state-of-the-art diffusion MRI data have the potential to help identify white matter tracts connecting DBS targets in functional neurosurgery intervention.
Collapse
Affiliation(s)
- Sonia Pujol
- Surgical Planning Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA
| | - Ryan Cabeen
- Department of Computer Science, Brown University, Providence RI, USA
| | - Sophie B Sébille
- Institut du Cerveau et de la Moëlle Epinière, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, University of Paris 06, UMR S 1127 Paris, France
| | - Jérôme Yelnik
- Institut du Cerveau et de la Moëlle Epinière, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, University of Paris 06, UMR S 1127 Paris, France
| | - Chantal François
- Institut du Cerveau et de la Moëlle Epinière, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, University of Paris 06, UMR S 1127 Paris, France
| | - Sara Fernandez Vidal
- Institut du Cerveau et de la Moëlle Epinière, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, University of Paris 06, UMR S 1127Paris, France; Centre de Neuro-Imagerie de Recherche, Institut du Cerveau et de la Moëlle EpinièreParis, France
| | - Carine Karachi
- Institut du Cerveau et de la Moëlle Epinière, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, University of Paris 06, UMR S 1127Paris, France; Department of Neurosurgery, Pitié-Salpêtrière HospitalParis, France
| | - Yulong Zhao
- LTSI, Inserm UMR 1099 - Université de Rennes Rennes, France
| | - G Rees Cosgrove
- Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA
| | - Pierre Jannin
- LTSI, Inserm UMR 1099 - Université de Rennes Rennes, France
| | - Ron Kikinis
- Surgical Planning Laboratory, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston MA, USA
| | - Eric Bardinet
- Institut du Cerveau et de la Moëlle Epinière, INSERM U 1127, CNRS UMR 7225, Sorbonne Universités, University of Paris 06, UMR S 1127Paris, France; Centre de Neuro-Imagerie de Recherche, Institut du Cerveau et de la Moëlle EpinièreParis, France
| |
Collapse
|
27
|
Sébille SB, Belaid H, Philippe AC, André A, Lau B, François C, Karachi C, Bardinet E. Anatomical evidence for functional diversity in the mesencephalic locomotor region of primates. Neuroimage 2016; 147:66-78. [PMID: 27956208 DOI: 10.1016/j.neuroimage.2016.12.011] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2016] [Revised: 11/25/2016] [Accepted: 12/05/2016] [Indexed: 01/26/2023] Open
Abstract
The mesencephalic locomotor region (MLR) is a highly preserved brainstem structure in vertebrates. The MLR performs a crucial role in locomotion but also controls various other functions such as sleep, attention, and even emotion. The MLR comprises the pedunculopontine (PPN) and cuneiform nuclei (CuN) but their specific roles are still unknown in primates. Here, we sought to characterise the inputs and outputs of the PPN and CuN to and from the basal ganglia, thalamus, amygdala and cortex, with a specific interest in identifying functional anatomical territories. For this purpose, we used tract-tracing techniques in monkeys and diffusion weighted imaging-based tractography in humans to understand structural connectivity. We found that MLR connections are broadly similar between monkeys and humans. The PPN projects to the sensorimotor, associative and limbic territories of the basal ganglia nuclei, the centre median-parafascicular thalamic nuclei and the central nucleus of the amygdala. The PPN receives motor cortical inputs and less abundant connections from the associative and limbic cortices. In monkeys, we found a stronger connection between the anterior PPN and motor cortex suggesting a topographical organisation of this specific projection. The CuN projected to similar cerebral structures to the PPN in both species. However, these projections were much stronger towards the limbic territories of the basal ganglia and thalamus, to the basal forebrain (extended amygdala) and the central nucleus of the amygdala, suggesting that the CuN is not primarily a motor structure. Our findings highlight the fact that the PPN integrates sensorimotor, cognitive and emotional information whereas the CuN participates in a more restricted network integrating predominantly emotional information.
Collapse
Affiliation(s)
- Sophie B Sébille
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France; Centre de Neuro-Imagerie de Recherche (CENIR), Paris, France
| | - Hayat Belaid
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France; Département de Neurochirurgie, Hôpital Pitie Salpêtrière, AP-HP, F-75013 Paris, France
| | - Anne-Charlotte Philippe
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France; Centre de Neuro-Imagerie de Recherche (CENIR), Paris, France
| | - Arthur André
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France; Département de Neurochirurgie, Hôpital Pitie Salpêtrière, AP-HP, F-75013 Paris, France
| | - Brian Lau
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France
| | - Chantal François
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France
| | - Carine Karachi
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France; Département de Neurochirurgie, Hôpital Pitie Salpêtrière, AP-HP, F-75013 Paris, France
| | - Eric Bardinet
- Sorbonne Universités, UPMC Univ Paris 06, CNRS, INSERM, APHP GH Pitié-Salpêtrière, Institut du cerveau et de la moelle épinière (ICM), F-75013 Paris, France; Centre de Neuro-Imagerie de Recherche (CENIR), Paris, France.
| |
Collapse
|
28
|
Baumgarten C, Zhao Y, Sauleau P, Malrain C, Jannin P, Haegelen C. Improvement of Pyramidal Tract Side Effect Prediction Using a Data-Driven Method in Subthalamic Stimulation. IEEE Trans Biomed Eng 2016; 64:2134-2141. [PMID: 27959795 DOI: 10.1109/tbme.2016.2638018] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE subthalamic nucleus deep brain stimulation (STN DBS) is limited by the occurrence of a pyramidal tract side effect (PTSE) induced by electrical activation of the pyramidal tract. Predictive models are needed to assist the surgeon during the electrode trajectory preplanning. The objective of the study was to compare two methods of PTSE prediction based on clinical assessment of PTSE induced by STN DBS in patients with Parkinson's disease. METHODS two clinicians assessed PTSE postoperatively in 20 patients implanted for at least three months in the STN. The resulting dataset of electroclinical tests was used to evaluate two methods of PTSE prediction. The first method was based on the volume of tissue activated (VTA) modeling and the second one was a data-driven-based method named Pyramidal tract side effect Model based on Artificial Neural network (PyMAN) developed in our laboratory. This method was based on the nonlinear correlation between the PTSE current threshold and the 3-D electrode coordinates. PTSE prediction from both methods was compared using Mann-Whitney U test. RESULTS 1696 electroclinical tests were used to design and compare the two methods. Sensitivity, specificity, positive- and negative-predictive values were significantly higher with the PyMAN method than with the VTA-based method (P < 0.05). CONCLUSION the PyMAN method was more effective than the VTA-based method to predict PTSE. SIGNIFICANCE this data-driven tool could help the neurosurgeon in predicting adverse side effects induced by DBS during the electrode trajectory preplanning.
Collapse
|
29
|
Gargouri F, Messé A, Perlbarg V, Valabregue R, McColgan P, Yahia-Cherif L, Fernandez-Vidal S, Ben Hamida A, Benali H, Tabrizi S, Durr A, Lehéricy S. Longitudinal changes in functional connectivity of cortico-basal ganglia networks in manifests and premanifest huntington's disease. Hum Brain Mapp 2016; 37:4112-4128. [PMID: 27400836 PMCID: PMC6867429 DOI: 10.1002/hbm.23299] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2016] [Accepted: 06/21/2016] [Indexed: 11/08/2022] Open
Abstract
Huntington's disease (HD) is a genetic neurological disorder resulting in cognitive and motor impairments. We evaluated the longitudinal changes of functional connectivity in sensorimotor, associative and limbic cortico-basal ganglia networks. We acquired structural MRI and resting-state fMRI in three visits one year apart, in 18 adult HD patients, 24 asymptomatic mutation carriers (preHD) and 18 gender- and age-matched healthy volunteers from the TRACK-HD study. We inferred topological changes in functional connectivity between 182 regions within cortico-basal ganglia networks using graph theory measures. We found significant differences for global graph theory measures in HD but not in preHD. The average shortest path length (L) decreased, which indicated a change toward the random network topology. HD patients also demonstrated increases in degree k, reduced betweeness centrality bc and reduced clustering C. Changes predominated in the sensorimotor network for bc and C and were observed in all circuits for k. Hubs were reduced in preHD and no longer detectable in HD in the sensorimotor and associative networks. Changes in graph theory metrics (L, k, C and bc) correlated with four clinical and cognitive measures (symbol digit modalities test, Stroop, Burden and UHDRS). There were no changes in graph theory metrics across sessions, which suggests that these measures are not reliable biomarkers of longitudinal changes in HD. preHD is characterized by progressive decreasing hub organization, and these changes aggravate in HD patients with changes in local metrics. HD is characterized by progressive changes in global network interconnectivity, whose network topology becomes more random over time. Hum Brain Mapp 37:4112-4128, 2016. © 2016 Wiley Periodicals, Inc.
Collapse
Affiliation(s)
- Fatma Gargouri
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Centre De NeuroImagerie De Recherche - CENIR, Paris, France
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France
- Advanced Technologies for Medicine and Signals - ATMS, Ecole Nationale D'Ingénieurs De Sfax - ENIS, Sfax Université, Tunisia
| | - Arnaud Messé
- Department of Computational Neuroscience, University Medical Center Eppendorf, Hamburg University, Germany
- Sorbonne Universités, UPMC Univ Paris 06, CNRS UMR 7371, Inserm UMR_S 1146, Laboratoire D'Imagerie Biomédicale, Paris, F-75013, France
| | - Vincent Perlbarg
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Centre De NeuroImagerie De Recherche - CENIR, Paris, France
- Sorbonne Universités, UPMC Univ Paris 06, CNRS UMR 7371, Inserm UMR_S 1146, Laboratoire D'Imagerie Biomédicale, Paris, F-75013, France
- Bioinformatics and Biostatistics platform - ICONICS, Institut Du Cerveau Et De La Moelle Épinière - ICM, Paris, France
| | - Romain Valabregue
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Centre De NeuroImagerie De Recherche - CENIR, Paris, France
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France
| | - Peter McColgan
- Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK
| | - Lydia Yahia-Cherif
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Centre De NeuroImagerie De Recherche - CENIR, Paris, France
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France
| | - Sara Fernandez-Vidal
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Centre De NeuroImagerie De Recherche - CENIR, Paris, France
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France
| | - Ahmed Ben Hamida
- Advanced Technologies for Medicine and Signals - ATMS, Ecole Nationale D'Ingénieurs De Sfax - ENIS, Sfax Université, Tunisia
| | - Habib Benali
- Sorbonne Universités, UPMC Univ Paris 06, CNRS UMR 7371, Inserm UMR_S 1146, Laboratoire D'Imagerie Biomédicale, Paris, F-75013, France
| | - Sarah Tabrizi
- Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK
| | - Alexandra Durr
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France
- Department of Genetics, APHP, University Hospital Pitié-Salpêtrière, Paris, France
| | - Stéphane Lehéricy
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Centre De NeuroImagerie De Recherche - CENIR, Paris, France.
- Institut Du Cerveau Et De La Moelle Épinière - ICM, Sorbonne Universités, UPMC Univ Paris 06, Inserm U1127, CNRS UMR 7225, Paris, France.
- ICM Team Control of Normal and Abnormal Movement.
- Groupe Hospitalier Pitié-Salpêtrière, Service De Neuroradiologie, Paris, France.
| |
Collapse
|
30
|
Garcia-Garcia D, Guridi J, Toledo JB, Alegre M, Obeso JA, Rodríguez-Oroz MC. Stimulation sites in the subthalamic nucleus and clinical improvement in Parkinson's disease: a new approach for active contact localization. J Neurosurg 2016; 125:1068-1079. [DOI: 10.3171/2015.9.jns15868] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/01/2023]
Abstract
OBJECTIVE
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is widely used in patients with Parkinson's disease (PD). However, which target area of this region results in the highest antiparkinsonian efficacy is still a matter of debate. The aim of this study was to develop a more accurate methodology to locate the electrodes and the contacts used for chronic stimulation (active contacts) in the subthalamic region, and to determine the position at which stimulation conveys the greatest clinical benefit.
METHODS
The study group comprised 40 patients with PD in whom bilateral DBS electrodes had been implanted in the STN. Based on the Morel atlas, the authors created an adaptable 3D atlas that takes into account individual anatomical variability and divides the STN into functional territories. The locations of the electrodes and active contacts were obtained from an accurate volumetric assessment of the artifact using preoperative and postoperative MR images. Active contacts were positioned in the 3D atlas using stereotactic coordinates and a new volumetric method based on an ellipsoid representation created from all voxels that belong to a set of contacts. The antiparkinsonian benefit of the stimulation was evaluated by the reduction in the Unified Parkinson's Disease Rating Scale Part III (UPDRS-III) score and in the levodopa equivalent daily dose (LEDD) at 6 months. A homogeneous group classification for contact position and the respective clinical improvement was applied using a hierarchical clustering method.
RESULTS
Subthalamic stimulation induced a significant reduction of 58.0% ± 16.5% in the UPDRS-III score (p < 0.001) and 64.9% ± 21.0% in the LEDD (p < 0.001). The greatest reductions in the total and contralateral UPDRS-III scores (64% and 76%, respectively) and in the LEDD (73%) were obtained when the active contacts were placed approximately 12 mm lateral to the midline, with no influence of the position being observed in the anteroposterior and dorsoventral axes. In contrast, contacts located about 10 mm from the midline only reduced the global and contralateral UPDRS-III scores by 47% and 41%, respectively, and the LEDD by 33%. Using the ellipsoid method of location, active contacts with the highest benefit were positioned in the rostral and most lateral portion of the STN and at the interface between this subthalamic region, the zona incerta, and the thalamic fasciculus. Contacts placed in the most medial regions of the motor STN area provided the lowest clinical efficacy.
CONCLUSIONS
The authors report an accurate new methodology to assess the position of electrodes and contacts used for chronic subthalamic stimulation. Using this approach, the highest antiparkinsonian benefit is achieved when active contacts are located within the rostral and the most lateral parts of the motor region of the STN and at the interface of this region and adjacent areas (zona incerta and thalamic fasciculus).
Collapse
Affiliation(s)
- David Garcia-Garcia
- 1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra Medical School, Pamplona
- 2Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); and
| | - Jorge Guridi
- 1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra Medical School, Pamplona
- 2Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); and
| | - Jon B. Toledo
- 1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra Medical School, Pamplona
| | - Manuel Alegre
- 1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra Medical School, Pamplona
| | - José A. Obeso
- 1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra Medical School, Pamplona
- 2Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); and
| | - María C. Rodríguez-Oroz
- 1Neurosciences Area, CIMA, Department of Neurology and Neurosurgery, Clínica Universidad de Navarra Medical School, Pamplona
- 2Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED); and
- 3Neuroscience Unit, BioDonostia Research Institute, University Hospital Donostia, Basque Center on Cognition, Brain and Language (BCBL), San Sebastián; Ikerbasque, Basque Foundation for Science, Bilbao, Spain
| |
Collapse
|
31
|
Babo-Rebelo M, Wolpert N, Adam C, Hasboun D, Tallon-Baudry C. Is the cardiac monitoring function related to the self in both the default network and right anterior insula? Philos Trans R Soc Lond B Biol Sci 2016; 371:rstb.2016.0004. [PMID: 28080963 PMCID: PMC5062094 DOI: 10.1098/rstb.2016.0004] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/05/2016] [Indexed: 11/12/2022] Open
Abstract
The self has been proposed to be rooted in the neural monitoring of internal bodily signals and might thus involve interoceptive areas, notably the right anterior insula (rAI). However, studies on the self consistently showed the involvement of midline default network (DN) nodes, without referring to visceral monitoring. Here, we investigate this apparent discrepancy. We previously showed that neural responses to heartbeats in the DN encode two different self-dimensions, the agentive ‘I’ and the introspective ‘Me’, in a whole-brain analysis of magnetoencephalography (MEG) data. Here, we confirm and anatomically refine this result with intracranial recordings (intracranial electroencephalography, iEEG). In two patients, we show a parametric modulation of neural responses to heartbeats by the self-relatedness of thoughts, at the single trial level. A region-of-interest analysis of the insula reveals that MEG responses to heartbeats in the rAI encode the ‘I’ self-dimension. The effect in rAI was weaker than in the DN and was replicated in iEEG data in one patient out of two. We propose that a common mechanism, the neural monitoring of cardiac signals, underlies the self in both the DN and rAI. This might reconcile studies on the self highlighting the DN, with studies on interoception focusing on the insula. This article is part of the themed issue ‘Interoception beyond homeostasis: affect, cognition and mental health’.
Collapse
Affiliation(s)
- Mariana Babo-Rebelo
- Laboratoire de Neurosciences Cognitives (ENS - INSERM U960), Département d'Etudes Cognitives, Ecole Normale Supérieure - PSL Research University, 75005 Paris, France
| | - Nicolai Wolpert
- Laboratoire de Neurosciences Cognitives (ENS - INSERM U960), Département d'Etudes Cognitives, Ecole Normale Supérieure - PSL Research University, 75005 Paris, France
| | - Claude Adam
- AP-HP, Groupe Hospitalier Pitié-Salpêtrière, Paris 75013, France
| | | | - Catherine Tallon-Baudry
- Laboratoire de Neurosciences Cognitives (ENS - INSERM U960), Département d'Etudes Cognitives, Ecole Normale Supérieure - PSL Research University, 75005 Paris, France
| |
Collapse
|
32
|
Gallea C, Popa T, García-Lorenzo D, Valabregue R, Legrand AP, Apartis E, Marais L, Degos B, Hubsch C, Fernández-Vidal S, Bardinet E, Roze E, Lehéricy S, Meunier S, Vidailhet M. Orthostatic tremor: a cerebellar pathology? Brain 2016; 139:2182-97. [PMID: 27329770 PMCID: PMC4958903 DOI: 10.1093/brain/aww140] [Citation(s) in RCA: 43] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/13/2016] [Accepted: 04/22/2016] [Indexed: 12/24/2022] Open
Abstract
SEE MUTHURAMAN ET AL DOI101093/AWW164 FOR A SCIENTIFIC COMMENTARY ON THIS ARTICLE: Primary orthostatic tremor is characterized by high frequency tremor affecting the legs and trunk during the standing position. Cerebellar defects were suggested in orthostatic tremor without direct evidence. We aimed to characterize the anatomo-functional defects of the cerebellar motor pathways in orthostatic tremor. We used multimodal neuroimaging to compare 17 patients with orthostatic tremor and 17 age- and gender-matched healthy volunteers. Nine of the patients with orthostatic tremor underwent repetitive transcranial stimulation applied over the cerebellum during five consecutive days. We quantified the duration of standing position and tremor severity through electromyographic recordings. Compared to healthy volunteers, grey matter volume in patients with orthostatic tremor was (i) increased in the cerebellar vermis and correlated positively with the duration of the standing position; and (ii) increased in the supplementary motor area and decreased in the lateral cerebellum, which both correlated with the disease duration. Functional connectivity between the lateral cerebellum and the supplementary motor area was abnormally increased in patients with orthostatic tremor, and correlated positively with tremor severity. After repetitive transcranial stimulation, tremor severity and functional connectivity between the lateral cerebellum and the supplementary motor area were reduced. We provide an explanation for orthostatic tremor pathophysiology, and demonstrate the functional relevance of cerebello-thalamo-cortical connections in tremor related to cerebellar defects.
Collapse
Affiliation(s)
- Cécile Gallea
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 5 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neuroradiologie, Paris, France
| | - Traian Popa
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France
| | - Daniel García-Lorenzo
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 5 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neuroradiologie, Paris, France
| | - Romain Valabregue
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 5 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neuroradiologie, Paris, France
| | | | - Emmanuelle Apartis
- 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 7 AP-HP, Hôpital de Saint-Antoine, Département de Neurologie, Paris, France
| | - Lea Marais
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 5 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neuroradiologie, Paris, France
| | - Bertrand Degos
- 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 8 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neurologie, Paris, France
| | - Cecile Hubsch
- 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 8 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neurologie, Paris, France
| | - Sara Fernández-Vidal
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France
| | - Eric Bardinet
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France
| | - Emmanuel Roze
- 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 8 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neurologie, Paris, France
| | - Stéphane Lehéricy
- 1 Centre de NeuroImagerie de Recherche - Institut du Cerveau et de la Moelle épinière, ICM, Paris, France 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 5 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neuroradiologie, Paris, France
| | - Sabine Meunier
- 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France
| | - Marie Vidailhet
- 2 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, Paris, France 3 CNRS, UMR 7225, Paris, France 4 Inserm, U 1127, Paris, France 8 AP-HP, Hôpital de la Pitié Salpêtrière, Département de Neurologie, Paris, France
| |
Collapse
|
33
|
Trenado C, Elben S, Petri D, Hirschmann J, Groiss SJ, Vesper J, Schnitzler A, Wojtecki L. Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans. J Vis Exp 2016. [PMID: 27286467 DOI: 10.3791/53466] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/31/2022] Open
Abstract
In spite of the success in applying non-invasive electroencephalography (EEG), magneto-encephalography (MEG) and functional magnetic resonance imaging (fMRI) for extracting crucial information about the mechanism of the human brain, such methods remain insufficient to provide information about physiological processes reflecting cognitive and emotional functions at the subcortical level. In this respect, modern invasive clinical approaches in humans, such as deep brain stimulation (DBS), offer a tremendous possibility to record subcortical brain activity, namely local field potentials (LFPs) representing coherent activity of neural assemblies from localized basal ganglia or thalamic regions. Notwithstanding the fact that invasive approaches in humans are applied only after medical indication and thus recorded data correspond to altered brain circuits, valuable insight can be gained regarding the presence of intact brain functions in relation to brain oscillatory activity and the pathophysiology of disorders in response to experimental cognitive paradigms. In this direction, a growing number of DBS studies in patients with Parkinson's disease (PD) target not only motor functions but also higher level processes such as emotions, decision-making, attention, memory and sensory perception. Recent clinical trials also emphasize the role of DBS as an alternative treatment in neuropsychiatric disorders ranging from obsessive compulsive disorder (OCD) to chronic disorders of consciousness (DOC). Consequently, we focus on the use of combined invasive (LFP) and non-invasive (EEG) human brain recordings in assessing the role of cortical-subcortical structures in cognitive and emotional processing trough experimental paradigms (e.g. speech stimuli with emotional connotation or paradigms of cognitive control such as the Flanker task), for patients undergoing DBS treatment.
Collapse
Affiliation(s)
- Carlos Trenado
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University
| | - Saskia Elben
- Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf
| | - David Petri
- Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf
| | - Jan Hirschmann
- Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf
| | - Stefan J Groiss
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University; Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf
| | - Jan Vesper
- Department of Neurosurgery, Functional Neurosurgery and Stereotaxy, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf
| | - Alfons Schnitzler
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University; Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf
| | - Lars Wojtecki
- Institute of Clinical Neuroscience and Medical Psychology, Medical Faculty, Heinrich-Heine-University; Department of Neurology, Center for Movement Disorders and Neuromodulation, University Clinic Düsseldorf;
| |
Collapse
|
34
|
Motor Improvement and Emotional Stabilization in Patients With Tourette Syndrome After Deep Brain Stimulation of the Ventral Anterior and Ventrolateral Motor Part of the Thalamus. Biol Psychiatry 2016; 79:392-401. [PMID: 25034948 DOI: 10.1016/j.biopsych.2014.05.014] [Citation(s) in RCA: 47] [Impact Index Per Article: 5.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/30/2013] [Revised: 04/24/2014] [Accepted: 05/14/2014] [Indexed: 11/21/2022]
Abstract
BACKGROUND Since its first application in 1999, the potential benefit of deep brain stimulation (DBS) in reducing symptoms of otherwise treatment-refractory Tourette syndrome (TS) has been documented in several publications. However, uncertainty regarding the ideal neural targets remains, and the eventuality of so far undocumented but possible negative long-term effects on personality fuels the debate about the ethical implications of DBS. METHODS In this prospective open-label trial, eight patients (three female, five male) 19-56 years old with severe and medically intractable TS were treated with high-frequency DBS of the ventral anterior and ventrolateral motor part of the thalamus. To assess the course of TS, its clinical comorbidities, personality parameters, and self-perceived quality of life, patients underwent repeated psychiatric assessments at baseline and 6 and 12 months after DBS onset. RESULTS Analysis indicated a strongly significant and beneficial effect of DBS on TS symptoms, trait anxiety, quality of life, and global functioning with an apparently low side-effect profile. In addition, presurgical compulsivity, anxiety, emotional dysregulation, and inhibition appeared to be significant predictors of surgery outcome. CONCLUSIONS Trading off motor effects and desirable side effects against surgery-related risks and negative implications, stimulation of the ventral anterior and ventrolateral motor part of the thalamus seems to be a valuable option when considering DBS for TS.
Collapse
|
35
|
Fleury V, Pollak P, Gere J, Tommasi G, Romito L, Combescure C, Bardinet E, Chabardes S, Momjian S, Krainik A, Burkhard P, Yelnik J, Krack P. Subthalamic stimulation may inhibit the beneficial effects of levodopa on akinesia and gait. Mov Disord 2016; 31:1389-97. [PMID: 26887333 DOI: 10.1002/mds.26545] [Citation(s) in RCA: 48] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/26/2015] [Revised: 12/15/2015] [Accepted: 12/16/2015] [Indexed: 11/09/2022] Open
Abstract
BACKGROUND Gait and akinesia deterioration in PD patients during the immediate postoperative period of DBS has been directly related to stimulation in the subthalamic region. The underlying mechanisms remain poorly understood. The aim of the present study was to clinically and anatomically describe this side effect. METHODS PD patients presenting with a worsening of gait and/or akinesia following STN-DBS, that was reversible on stimulation arrest were included. The evaluation included (1) a Stand Walk Sit Test during a monopolar survey of each electrode in the on-drug condition; (2) a 5-condition test with the following conditions: off-drug/off-DBS, off-drug/on-best-compromise-DBS, on-drug/off-DBS, on-drug/on-best-compromise-DBS, and on-drug/on-worsening-DBS, which utilized the contact inducing the most prominent gait deterioration. The following scales were performed: UPDRSIII subscores, Stand Walk Sit Test, and dyskinesia and freezing of gait scales. Localization of contacts was performed using a coregistration method. RESULTS Twelve of 17 patients underwent the complete evaluation. Stimulation of the most proximal contacts significantly slowed down the Stand Walk Sit Test. The on-drug/on-worsening-DBS condition compared with the on-drug/off-DBS condition worsened akinesia (P = 0.02), Stand Walk Sit Test (P = 0.001), freezing of gait (P = 0.02), and improved dyskinesias (P = 0.003). Compared with the off-drug/off-DBS condition, the on-drug/on-worsening-DBS condition improved rigidity (P = 0.007) and tremor (P = 0.007). Worsening contact sites were predominantly dorsal and anterior to the STN in the anterior zona incerta and Forel fields H2. CONCLUSIONS A paradoxical deterioration of gait and akinesia is a rare side effect following STN-DBS. We propose that this may be related to misplaced contacts, and we discuss the pathophysiology and strategies to identify and manage this complication. © 2016 International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Vanessa Fleury
- Department of Neurology, Geneva University Hospital, Geneva, Switzerland. .,Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France.
| | - Pierre Pollak
- Department of Neurology, Geneva University Hospital, Geneva, Switzerland.,Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France
| | - Julien Gere
- Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France.,Department of Neurology, Savoie Hospital, Chambery, France
| | - Giorgio Tommasi
- Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France.,Department of Neurology, University Hospital of Verona, Verona, Italy
| | - Luigi Romito
- Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France.,Department of Neurology, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milano, Italy
| | - Christophe Combescure
- Department of Health and Community Medicine, Geneva University Hospital, Geneva, Switzerland
| | - Eric Bardinet
- Sorbonne Université, UPMC Univ Paris, Inserm U975, CNRS UMR 7225, Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle Épinière, Paris, France
| | - Stephan Chabardes
- Department of Neurosurgery, Grenoble University Hospital, Grenoble, France
| | - Shahan Momjian
- Department of Neurosurgery, Geneva University Hospital, Geneva, Switzerland
| | - Alexandre Krainik
- US 017, INSERM, UMS 3552, CNRS, Grenoble University Hospital, Neuroradiology and MRI, Grenoble, France
| | - Pierre Burkhard
- Department of Neurology, Geneva University Hospital, Geneva, Switzerland
| | - Jérôme Yelnik
- Sorbonne Université, UPMC Univ Paris, Inserm U975, CNRS UMR 7225, Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle Épinière, Paris, France
| | - Paul Krack
- Movement Disorder Unit, Department of Psychiatry and Neurology, Grenoble University Hospital, Grenoble, France.,INSERM U836, University Grenoble Alpes, Grenoble Neuroscience Institute, Grenoble, France
| |
Collapse
|
36
|
Connections of the dorsolateral prefrontal cortex with the thalamus: a probabilistic tractography study. Surg Radiol Anat 2015; 38:705-10. [DOI: 10.1007/s00276-015-1603-8] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2015] [Accepted: 12/05/2015] [Indexed: 01/30/2023]
|
37
|
PPNa-DBS for gait and balance disorders in Parkinson’s disease: a double-blind, randomised study. J Neurol 2015; 262:1515-25. [DOI: 10.1007/s00415-015-7744-1] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2014] [Revised: 04/08/2015] [Accepted: 04/10/2015] [Indexed: 10/23/2022]
|
38
|
Welter ML, Grabli D, Karachi C, Jodoin N, Fernandez-Vidal S, Brun Y, Navarro S, Rogers A, Cornu P, Pidoux B, Yelnik J, Roze E, Bardinet E, Vidailhet M. Pallidal activity in myoclonus dystonia correlates with motor signs. Mov Disord 2015; 30:992-6. [PMID: 25880339 DOI: 10.1002/mds.26244] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2014] [Revised: 03/18/2015] [Accepted: 03/21/2015] [Indexed: 11/06/2022] Open
Abstract
BACKGROUND Myoclonus-dystonia related to epsilon-sarcoglycan gene mutations is characterized by myoclonic jerks and mild to moderate dystonia. The role of basal ganglia dysfunction in the pathogenesis is unknown. METHODS Pallidal neuronal activity was recorded in six myoclonus-dystonia and six primary generalized dystonia patients operated on for internal globus pallidus deep brain stimulation. RESULTS In myoclonus-dystonia patients compared with primary-dystonia patients, internal pallidum neurons showed higher burst frequency, lower mean burst, and pause durations. External pallidum neurons showed higher mean pause frequency. Oscillatory activity was present in 33% and 35% of internal pallidum neurons in myoclonus-dystonia and primary-dystonia patients, respectively, predominantly in the theta frequency band (3-8 Hz). In myoclonus-dystonia patients with more severe myoclonus, internal pallidum neurons exhibited a higher bursting activity with high intraburst frequency and lower oscillatory activity frequency. CONCLUSIONS Myoclonus-dystonia appears to be related to specific changes in internal pallidum activity, leading to disruption in striato-pallido-thalamo-cortical circuits. © 2015 International Parkinson and Movement Disorder Society.
Collapse
Affiliation(s)
- Marie-Laure Welter
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France.,Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.,Département de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - David Grabli
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France.,Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.,Département de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Carine Karachi
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France.,Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.,Service de Neurochirurgie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Nicolas Jodoin
- Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.,Service de Neurologie, Centre hospitalier de l'Université de Montréal, Montréal, Québec, Canada
| | - Sara Fernandez-Vidal
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Centre de Neuroimagerie de Recherche (CENIR), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
| | - Yohann Brun
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France
| | - Soledad Navarro
- Service de Neurochirurgie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Alister Rogers
- Service de Neurochirurgie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Philippe Cornu
- Service de Neurochirurgie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Bernard Pidoux
- Service de Neurochirurgie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Jérôme Yelnik
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France.,Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Emmanuel Roze
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France.,Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.,Département de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| | - Eric Bardinet
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Centre de Neuroimagerie de Recherche (CENIR), Groupe Hospitalier Pitié-Salpêtrière, Paris, France
| | - Marie Vidailhet
- Université Pierre et Marie Curie-Paris 6, Centre de Recherche de l'Institut du Cerveau et de la Moelle épiniere (CRICM), UMR-S975, Paris, France.,Inserm, U1127, Paris, France.,CNRS, UMR 7225, Paris, France.,Centre d'Investigation Clinique Pitié Neurosciences (Inserm CIC-1422), Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.,Département de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France
| |
Collapse
|
39
|
Lau B, Welter ML, Belaid H, Fernandez Vidal S, Bardinet E, Grabli D, Karachi C. The integrative role of the pedunculopontine nucleus in human gait. Brain 2015; 138:1284-96. [PMID: 25765327 DOI: 10.1093/brain/awv047] [Citation(s) in RCA: 70] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2014] [Accepted: 01/06/2015] [Indexed: 01/20/2023] Open
Abstract
The brainstem pedunculopontine nucleus has a likely, although unclear, role in gait control, and is a potential deep brain stimulation target for treating resistant gait disorders. These disorders are a major therapeutic challenge for the ageing population, especially in Parkinson's disease where gait and balance disorders can become resistant to both dopaminergic medication and subthalamic nucleus stimulation. Here, we present electrophysiological evidence that the pedunculopontine and subthalamic nuclei are involved in distinct aspects of gait using a locomotor imagery task in 14 patients with Parkinson's disease undergoing surgery for the implantation of pedunculopontine or subthalamic nuclei deep brain stimulation electrodes. We performed electrophysiological recordings in two phases, once during surgery, and again several days after surgery in a subset of patients. The majority of pedunculopontine nucleus neurons (57%) recorded intrasurgically exhibited changes in activity related to different task components, with 29% modulated during visual stimulation, 41% modulated during voluntary hand movement, and 49% modulated during imaginary gait. Pedunculopontine nucleus local field potentials recorded post-surgically were modulated in the beta and gamma bands during visual and motor events, and we observed alpha and beta band synchronization that was sustained for the duration of imaginary gait and spatially localized within the pedunculopontine nucleus. In contrast, significantly fewer subthalamic nucleus neurons (27%) recorded intrasurgically were modulated during the locomotor imagery, with most increasing or decreasing activity phasically during the hand movement that initiated or terminated imaginary gait. Our data support the hypothesis that the pedunculopontine nucleus influences gait control in manners extending beyond simply driving pattern generation. In contrast, the subthalamic nucleus seems to control movement execution that is not likely to be gait-specific. These data highlight the crucial role of these two nuclei in motor control and shed light on the complex functions of the lateral mesencephalus in humans.
Collapse
Affiliation(s)
- Brian Lau
- 1 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013, Paris, France
| | - Marie-Laure Welter
- 1 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013, Paris, France 2 Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75013 Paris, France
| | - Hayat Belaid
- 2 Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75013 Paris, France
| | - Sara Fernandez Vidal
- 1 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013, Paris, France 3 Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle épinière, F-75013, Paris, France
| | - Eric Bardinet
- 1 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013, Paris, France 3 Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle épinière, F-75013, Paris, France
| | - David Grabli
- 1 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013, Paris, France 2 Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75013 Paris, France
| | - Carine Karachi
- 1 Sorbonne Universités, UPMC Univ Paris 06, UMR S 1127, CNRS UMR 7225, ICM, F-75013, Paris, France 2 Assistance Publique-Hôpitaux de Paris, Groupe Hospitalier Pitié-Salpêtrière, 47 boulevard de l'Hôpital, 75013 Paris, France
| |
Collapse
|
40
|
Tommasi G, Fiorio M, Yelnik J, Krack P, Sala F, Schmitt E, Fraix V, Bertolasi L, Le Bas JF, Ricciardi GK, Fiaschi A, Theeuwes J, Pollak P, Chelazzi L. Disentangling the Role of Cortico-Basal Ganglia Loops in Top-Down and Bottom-Up Visual Attention: An Investigation of Attention Deficits in Parkinson Disease. J Cogn Neurosci 2014; 27:1215-37. [PMID: 25514652 DOI: 10.1162/jocn_a_00770] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
It is solidly established that top-down (goal-driven) and bottom-up (stimulus-driven) attention mechanisms depend on distributed cortical networks, including prefrontal and frontoparietal regions. On the other hand, it is less clear whether the BG also contribute to one or the other of these mechanisms, or to both. The current study was principally undertaken to clarify this issue. Parkinson disease (PD), a neurodegenerative disorder primarily affecting the BG, has proven to be an effective model for investigating the contribution of the BG to different brain functions; therefore, we set out to investigate deficits of top-down and bottom-up attention in a selected cohort of PD patients. With this objective in mind, we compared the performance on three computerized tasks of two groups of 12 parkinsonian patients (assessed without any treatment), one otherwise pharmacologically treated and the other also surgically treated, with that of a group of controls. The main behavioral tool for our study was an attentional capture task, which enabled us to tap the competition between top-down and bottom-up mechanisms of visual attention. This task was suitably combined with a choice RT and a simple RT task to isolate any specific deficit of attention from deficits in motor response selection and initiation. In the two groups of patients, we found an equivalent increase of attentional capture but also comparable delays in target selection in the absence of any salient distractor (reflecting impaired top-down mechanisms) and movement initiation compared with controls. In contrast, motor response selection processes appeared to be prolonged only in the operated patients. Our results confirm that the BG are involved in both motor and cognitive domains. Specifically, damage to the BG, as it occurs in PD, leads to a distinct deficit of top-down control of visual attention, and this can account, albeit indirectly, for the enhancement of attentional capture, reflecting weakened ability of top-down mechanisms to antagonize bottom-up control.
Collapse
|
41
|
Wojtecki L, Petri D, Elben S, Hirschmann J, Yelnik J, Eickhoff S, Vesper J, Schnitzler A. Modulation of central thalamic oscillations during emotional-cognitive processing in chronic disorder of consciousness. Cortex 2014; 60:94-102. [DOI: 10.1016/j.cortex.2014.09.007] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/07/2013] [Revised: 06/16/2014] [Accepted: 09/10/2014] [Indexed: 11/29/2022]
|
42
|
Fleury V, Spielberger S, Wolf E, Yelnik J, Fraix V, Poewe W, Pollak P. Vertical supranuclear gaze palsy induced by deep brain stimulation: report of two cases. Parkinsonism Relat Disord 2014; 20:1295-7. [PMID: 25172124 DOI: 10.1016/j.parkreldis.2014.07.007] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/02/2014] [Revised: 07/04/2014] [Accepted: 07/12/2014] [Indexed: 11/30/2022]
Affiliation(s)
- Vanessa Fleury
- Department of Neurology, Geneva University Hospital, Site Cluse-Roseraie, Rue Micheli-du-Crest 24, 1211 Geneva 14, Switzerland.
| | - Sabine Spielberger
- Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - Elisabeth Wolf
- Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - Jérôme Yelnik
- Pierre and Marie Curie University-Paris 6, Centre de Recherche de l'Institut du cerveau et de la Moelle épinière, Paris, France
| | - Valérie Fraix
- Department of Neurology, Grenoble University Hospital, Grenoble, France
| | - Werner Poewe
- Department of Neurology, Medical University Innsbruck, Innsbruck, Austria
| | - Pierre Pollak
- Department of Neurology, Geneva University Hospital, Geneva, Switzerland
| |
Collapse
|
43
|
Abstract
Recent advances in structural and functional imaging have greatly improved our ability to assess normal functions of the basal ganglia, diagnose parkinsonian syndromes, understand the pathophysiology of parkinsonism and other movement disorders, and detect and monitor disease progression. Radionuclide imaging is the best way to detect and monitor dopamine deficiency, and will probably continue to be the best biomarker for assessment of the effects of disease-modifying therapies. However, advances in magnetic resonance enable the separation of patients with Parkinson's disease from healthy controls, and show great promise for differentiation between Parkinson's disease and other akinetic-rigid syndromes. Radionuclide imaging is useful to show the dopaminergic basis for both motor and behavioural complications of Parkinson's disease and its treatment, and alterations in non-dopaminergic systems. Both PET and MRI can be used to study patterns of functional connectivity in the brain, which is disrupted in Parkinson's disease and in association with its complications, and in other basal-ganglia disorders such as dystonia, in which an anatomical substrate is not otherwise apparent. Functional imaging is increasingly used to assess underlying pathological processes such as neuroinflammation and abnormal protein deposition. This imaging is another promising approach to assess the effects of treatments designed to slow disease progression.
Collapse
Affiliation(s)
- A Jon Stoessl
- Pacific Parkinson's Research Centre and National Parkinson Foundation Centre of Excellence, University of British Columbia and Vancouver Coastal Health, Vancouver, BC, Canada.
| | - Stephane Lehericy
- Institut National de la Santé et de la Recherche Médicale, U 1127, F-75013, Paris, France; Centre National de la Recherche Scientifique, Unite Mixte de Recherche 7225, F-75013, Paris, France; Sorbonne Universités, Université Pierre et Marie Curie, Paris 06, Unite Mixte de Recherche S 1127, F-75013, Paris, France; Institut du Cerveau et de la Moelle épinière, ICM (Centre de NeuroImagerie de Recherche, CENIR), F-75013, Paris, France; Assistance Publique, Hopitaux de Paris, Hôpital de la Pitié Salpêtrière, Service de Neuroradiologie F-75013, Paris, France
| | - Antonio P Strafella
- Morton and Gloria Shulman Movement Disorder Unit and E J Safra Parkinson Disease Program, University of Toronto, Toronto, ON, Canada; Division of Brain, Imaging and Behaviour-Systems Neuroscience, Toronto Western Hospital and Research Institute, University Health Network, University of Toronto, Toronto, ON, Canada; Research Imaging Centre, Centre for Addiction and Mental Health, University of Toronto, Toronto, ON, Canada
| |
Collapse
|
44
|
Cooper SE, Driesslein KG, Noecker AM, McIntyre CC, Machado AM, Butson CR. Anatomical targets associated with abrupt versus gradual washout of subthalamic deep brain stimulation effects on bradykinesia. PLoS One 2014; 9:e99663. [PMID: 25098453 PMCID: PMC4123847 DOI: 10.1371/journal.pone.0099663] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2013] [Accepted: 05/19/2014] [Indexed: 11/18/2022] Open
Abstract
The subthalamic nucleus (STN) is a common anatomical target for deep brain stimulation (DBS) for the treatment of Parkinson’s disease. However, the effects of stimulation may spread beyond the STN. Ongoing research aims to identify nearby anatomical structures where DBS-induced effects could be associated with therapeutic improvement or side effects. We previously found that DBS lead location determines the rate – abrupt vs. gradual – with which therapeutic effect washes out after stimulation is stopped. Those results suggested that electrical current spreads from the electrodes to two spatially distinct stimulation targets associated with different washout rates. In order to identify these targets we used computational models to predict the volumes of tissue activated during DBS in 14 Parkinson’s patients from that study. We then coregistered each patient with a stereotaxic atlas and generated a probabilistic stimulation atlas to obtain a 3-dimensional representation of regions where stimulation was associated with abrupt vs. gradual washout. We found that the therapeutic effect which washed out gradually was associated with stimulation of the zona incerta and fields of Forel, whereas abruptly-disappearing therapeutic effect was associated with stimulation of STN itself. This supports the idea that multiple DBS targets exist and that current spread from one electrode may activate more than one of them in a given patient, producing a combination of effects which vary according to electrode location and stimulation settings.
Collapse
Affiliation(s)
- Scott E. Cooper
- Cleveland Clinic, Center for Neurological Restoration, Cleveland, Ohio, United States of America
- * E-mail:
| | - Klaus G. Driesslein
- Medical College of Wisconsin, Departments of Neurology & Neurosurgery, Biotechnology and Bioengineering Center, Milwaukee, Wisconsin, United States of America
| | - Angela M. Noecker
- Case Western Reserve University, Department of Biomedical Engineering, Cleveland, Ohio, United States of America
| | - Cameron C. McIntyre
- Case Western Reserve University, Department of Biomedical Engineering, Cleveland, Ohio, United States of America
| | - Andre M. Machado
- Cleveland Clinic, Center for Neurological Restoration, Cleveland, Ohio, United States of America
| | - Christopher R. Butson
- Medical College of Wisconsin, Departments of Neurology & Neurosurgery, Biotechnology and Bioengineering Center, Milwaukee, Wisconsin, United States of America
| |
Collapse
|
45
|
Millet B, Jaafari N, Polosan M, Baup N, Giordana B, Haegelen C, Chabardes S, Fontaine D, Devaux B, Yelnik J, Fossati P, Aouizerate B, Krebs MO, Robert G, Jay T, Cornu P, Vérin M, Drapier S, Drapier D, Sauleau P, Peron J, Le Jeune F, Naudet F, Reymann JM. Limbic versus cognitive target for deep brain stimulation in treatment-resistant depression: accumbens more promising than caudate. Eur Neuropsychopharmacol 2014; 24:1229-39. [PMID: 24950819 DOI: 10.1016/j.euroneuro.2014.05.006] [Citation(s) in RCA: 42] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/29/2013] [Revised: 03/10/2014] [Accepted: 05/09/2014] [Indexed: 11/24/2022]
Abstract
High-frequency deep brain stimulation (DBS) represents a major stake for treatment for treatment-resistant depression (TRD). We describe a preliminary trial of DBS of two potential brain targets in chronic TRD: the nucleus accumbens (Acb) and, in the event of failure, the caudate nucleus. Patients were followed for 6 months before surgery (M0). From M1 to M5, they underwent stimulation of the Acb target. PET scans allowed us to track metabolic modifications resulting from this stimulation. The caudate target of nonresponders was stimulated between M5 and M9. Patients then entered an extension phase, in which it was possible to adapt stimulation parameters and treatments. Six patients were included and four were operated on. At M5, none of the patients were either responders or remitters, but we did observe a decrease in Hamilton Depression Rating Scale (HDRS) scores. Three patients were switched to caudate stimulation, but no improvement was observed. During the extension phase, the Acb target was stimulated for all patients, three of whom exhibited a significant response. A decrease in glucose metabolism was observed after Acb stimulation, in the posterior cingulate gyrus, left frontal lobe, superior and medial gyrus, and bilateral cerebellum. An increase in metabolism was observed in the bilateral frontal lobe (superior gyrus), left frontal lobe (medial gyrus), and right limbic lobe (anterior cingulate gyrus). The results of this trial suggest that Acb is a more promising target than the caudate. NCT01569711.
Collapse
Affiliation(s)
- Bruno Millet
- University Department of Adult Psychiatry, Guillaume Régnier Hospital, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France
| | - Nematollah Jaafari
- Intersector Clinical Psychiatric Research Unit (INSERM U 1084), Psychobiology of Compulsive Disorders Team, Experimental and Clinical Neurosciences Laboratory, Henri Laborit Hospital, University of Poitiers, France
| | - Mircea Polosan
- D Villars Ward (Adult Psychiatry), Department of Psychiatry and Neurology, North Hospital, University Hospital, Grenoble, France
| | - Nicolas Baup
- Adolescent and Young Adult Assessment Center, Sainte-Anne Hospital, Paris, France
| | - Bruno Giordana
- Psychiatry and Medical Psychology Clinic, University Department of Clinical Neuroscience, Pasteur University Hospital, Nice, France
| | - Claire Haegelen
- Department of Neurosurgery, Pontchaillou University Hospital, Rennes, France
| | | | - Denys Fontaine
- Department of Neurosurgery, Pasteur University Hospital, Nice, France
| | - Bertrand Devaux
- Department of Neurosurgery, Sainte-Anne Hospital, Paris, France
| | - Jérome Yelnik
- CRICM UPMC/INSERM UMR S 975, CNRS UMR 7225, La Salpêtrière Hospital, Paris, France
| | - Philippe Fossati
- Department of Psychiatry, Pitié-Salpêtrière Hospital, Paris, France
| | - Bruno Aouizerate
- University Department of Adult Psychiatry, Charles Perrens Hospital, Bordeaux, France
| | - Marie Odile Krebs
- Adolescent and Young Adult Assessment Center, Sainte-Anne Hospital, Paris, France
| | - Gabriel Robert
- University Department of Adult Psychiatry, Guillaume Régnier Hospital, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France
| | - Thérèse Jay
- Inserm U894, Center for Psychiatry and Neuroscience, Paris Descartes University, Paris, France
| | - Philippe Cornu
- Department of Neurosurgery, Pitié-Salpêtrière Hospital, Paris, France
| | - Marc Vérin
- Department of Neurology, Pontchaillou University Hosptial, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France
| | - Sophie Drapier
- Department of Neurology, Pontchaillou University Hospital, Rennes, France
| | - Dominique Drapier
- University Department of Adult Psychiatry, Guillaume Régnier Hospital, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France
| | - Paul Sauleau
- Functional Neurological Exploration Unit, Pontchaillou University Hospital, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France
| | - Julie Peron
- Swiss Center for Affective Sciences, University of Geneva, Geneva, Switzerland
| | - Florence Le Jeune
- Department of Nuclear Medicine, Eugène Marquis Center, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France
| | - Florian Naudet
- Clinical Investigation Center (INSERM 0203), Department of Pharmacology, Pontchaillou University Hospital, Rennes, France; Behavior and Basal Ganglia Unit (EA-4712), University of Rennes 1, Rennes, France.
| | - Jean Michel Reymann
- Clinical Investigation Center (INSERM 0203), Department of Pharmacology, Pontchaillou University Hospital, Rennes, France
| |
Collapse
|
46
|
Laouchedi M, Galanaud D, Delmaire C, Fernandez-Vidal S, Messé A, Mesmoudi S, Oulebsir Boumghar F, Pélégrini-Issac M, Puybasset L, Benali H, Perlbarg V. Deafferentation in thalamic and pontine areas in severe traumatic brain injury. J Neuroradiol 2014; 42:202-11. [PMID: 24997478 DOI: 10.1016/j.neurad.2014.03.001] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/04/2014] [Revised: 03/19/2014] [Accepted: 03/19/2014] [Indexed: 11/25/2022]
Abstract
PURPOSE Severe traumatic brain injury (TBI) is characterized mainly by diffuse axonal injuries (DAI). The cortico-subcortical disconnections induced by such fiber disruption play a central role in consciousness recovery. We hypothesized that these cortico-subcortical deafferentations inferred from diffusion MRI data could differentiate between TBI patients with favorable or unfavorable (death, vegetative state, or minimally conscious state) outcome one year after injury. METHODS Cortico-subcortical fiber density maps were derived by using probabilistic tractography from diffusion tensor imaging data acquired in 24 severe TBI patients and 9 healthy controls. These maps were compared between patients and controls as well as between patients with favorable (FO) and unfavorable (UFO) 1-year outcome to identify the thalamo-cortical and ponto-thalamo-cortical pathways involved in the maintenance of consciousness. RESULTS Thalamo-cortical and ponto-thalamo-cortical fiber density was significantly lower in TBI patients than in healthy controls. Comparing FO and UFO TBI patients showed thalamo-cortical deafferentation associated with unfavorable outcome for projections from ventral posterior and intermediate thalamic nuclei to the associative frontal, sensorimotor and associative temporal cortices. Specific ponto-thalamic deafferentation in projections from the upper dorsal pons (including the reticular formation) was also associated with unfavorable outcome. CONCLUSION Fiber density of cortico-subcortical pathways as measured from diffusion MRI tractography is a relevant candidate biomarker for early prediction of one-year favorable outcome in severe TBI.
Collapse
Affiliation(s)
- M Laouchedi
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France; ParIMed Team, LRPE, USTHB, Algiers, Algeria
| | - D Galanaud
- AP-HP, Pitié-Salpêtrière Hospital, Department of Neuroradiology, Paris, France
| | - C Delmaire
- CHRU de Lille, Department of Neuroradiology, Lille, France
| | - S Fernandez-Vidal
- Inserm and UPMC université Paris 06, UMR-S 975, CNRS, UMR 7225, centre de recherche de l'institut du cerveau et de la moelle épinière, Paris, France; Institut du cerveau et de la moelle épinière, centre de neuroimagerie de recherche, Paris, France
| | - A Messé
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France
| | - S Mesmoudi
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France; MATRICE Project University Paris 1 Panthéon-Sorbonne, Paris, France
| | | | - M Pélégrini-Issac
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France
| | - L Puybasset
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France; AP-HP, Pitié-Salpêtrière Hospital, Surgical Neuro-Intensive Care Unit, Paris, France
| | - H Benali
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France
| | - V Perlbarg
- Inserm U1146, CNRS UMR7371, laboratoire d'imagerie biomédicale, Sorbonne universités, UPMC université Paris 06 UMCR2, CHU Pitié-Salpêtrière, 91, boulevard de l'hôpital, 75634 Paris, France.
| |
Collapse
|
47
|
Xiao Y, Fonov V, Bériault S, Subaie FA, Chakravarty MM, Sadikot AF, Pike GB, Collins DL. Multi-contrast unbiased MRI atlas of a Parkinson’s disease population. Int J Comput Assist Radiol Surg 2014; 10:329-41. [DOI: 10.1007/s11548-014-1068-y] [Citation(s) in RCA: 56] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2013] [Accepted: 04/29/2014] [Indexed: 11/24/2022]
|
48
|
Welter ML, Schüpbach M, Czernecki V, Karachi C, Fernandez-Vidal S, Golmard JL, Serra G, Navarro S, Welaratne A, Hartmann A, Mesnage V, Pineau F, Cornu P, Pidoux B, Worbe Y, Zikos P, Grabli D, Galanaud D, Bonnet AM, Belaid H, Dormont D, Vidailhet M, Mallet L, Houeto JL, Bardinet E, Yelnik J, Agid Y. Optimal target localization for subthalamic stimulation in patients with Parkinson disease. Neurology 2014; 82:1352-61. [PMID: 24647024 PMCID: PMC4001189 DOI: 10.1212/wnl.0000000000000315] [Citation(s) in RCA: 118] [Impact Index Per Article: 11.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Abstract
Objective: To further determine the causes of variable outcome from deep brain stimulation of the subthalamic nucleus (DBS-STN) in patients with Parkinson disease (PD). Methods: Data were obtained from our cohort of 309 patients with PD who underwent DBS-STN between 1996 and 2009. We examined the relationship between the 1-year motor, cognitive, and psychiatric outcomes and (1) preoperative PD clinical features, (2) MRI measures, (3) surgical procedure, and (4) locations of therapeutic contacts. Results: Pre- and postoperative results were obtained in 262 patients with PD. The best motor outcome was obtained when stimulating contacts were located within the STN as compared with the zona incerta (64% vs 49% improvement). Eighteen percent of the patients presented a postoperative cognitive decline, which was found to be principally related to the surgical procedure. Other factors predictive of poor cognitive outcome were perioperative confusion and psychosis. Nineteen patients showed a stimulation-induced hypomania, which was related to both the form of the disease (younger age, shorter disease duration, higher levodopa responsiveness) and the ventral contact location. Postoperative depression was more frequent in patients already showing preoperative depressive and/or residual axial motor symptoms. Conclusion: In this homogeneous cohort of patients with PD, we showed that (1) the STN is the best target to improve motor symptoms, (2) postoperative cognitive deficit is mainly related to the surgery itself, and (3) stimulation-induced hypomania is related to a combination of both the disease characteristics and a more ventral STN location.
Collapse
Affiliation(s)
- Marie-Laure Welter
- From the Université Pierre et Marie Curie-Paris 6 (M.-L.W., M.S., V.C., C.K., S.F.-V., J.-L.G., A.H., V.M., F.P., Y.W., D. Grabli, D. Galanaud, D.D., M.V., L.M., E.B., J.Y., Y.A.), Centre de Recherche de l'Institut du Cerveau et de, la Moelle épinière, UMR-S975, Paris; Inserm (M.-L.W., M.S., V.C., C.K., S.F.-V., A.H., V.M., F.P., Y.W., D. Grabli, D. Galanaud, D.D., M.V., L.M., E.B., J.Y., Y.A.), U975, Paris; CNRS (M.-L.W., M.S., C.K., S.F.-V., A.H., V.M., F.P., Y.W., D. Grabli, D. Galanaud, D.D., M.V., L.M., E.B., J.Y., Y.A.), UMR 7225, Paris; Centre d'Investigation Clinique (M.-L.W., M.S., C.K., G.S., A.H., V.M., F.P., Y.W., P.Z., D. Grabli, A.-M.B., M.V., Y.A.), Département de Neurologie (M.-L.W., V.C., A.W., A.H., V.M., D. Grabli, A.-M.B., M.V., Y.A.), IM2A (V.C., F.P.), Service de Neurochirurgie (C.K., S.N., P.C., H.B.), Department of Clinical Neurophysiology (B.P.), and Service de Neuroradiologie Diagnostique et Fonctionnelle (D. Galanaud, D.D.), Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Assistance Publique-Hôpitaux de Paris, France; Department of Neurology (M.S.), University Hospital, Bern, Switzerland; Centre de Neuroimagerie de Recherche (S.F.-V., D. Galanaud, D.D.), Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Paris, France; Département de Biostatistiques et Information Médicale (J.-L.G.), Hôpitaux Universitaires Pitié-Salpêtrière/Charles Foix, Assistance Publique-Hôpitaux de Paris, ER4 (ex EA3974) Modélisation en Recherche Clinique, Paris, France; Department of Neurology (P.Z.), 251 Hellenic Air Force General Hospital, Athens, Greece; and Department of Neurology (J.-L.H.), CHU Poitiers, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
49
|
Atlas-Based Transfer of Boundary Conditions for Biomechanical Simulation. MEDICAL IMAGE COMPUTING AND COMPUTER-ASSISTED INTERVENTION – MICCAI 2014 2014; 17:33-40. [DOI: 10.1007/978-3-319-10470-6_5] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
|
50
|
Plantefève R, Haouchine N, Radoux JP, Cotin S. Automatic Alignment of Pre and Intraoperative Data Using Anatomical Landmarks for Augmented Laparoscopic Liver Surgery. BIOMEDICAL SIMULATION 2014. [DOI: 10.1007/978-3-319-12057-7_7] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/11/2023]
|